<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.6.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art560.dtd?><?SourceDTD.Version 5.6.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?FILEmeta_CELREP6499 xml ?><?FILEmain xml ?><?FILEgr1 jpg ?><?FILEgr2 jpg ?><?FILEgr3 jpg ?><?FILEgr4 jpg ?><?FILEgr5 jpg ?><?FILEgr6 jpg ?><?FILEfx1 jpg ?><?FILEmmc1 pdf ?><?FILEmmc2 pdf ?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cell Rep</journal-id><journal-id journal-id-type="iso-abbrev">Cell Rep</journal-id><journal-title-group><journal-title>Cell Reports</journal-title></journal-title-group><issn pub-type="epub">2211-1247</issn><publisher><publisher-name>Cell Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6635384</article-id><article-id pub-id-type="publisher-id">S2211-1247(19)30805-8</article-id><article-id pub-id-type="doi">10.1016/j.celrep.2019.06.039</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Acute Iron Deprivation Reprograms Human Macrophage Metabolism and Reduces Inflammation <italic>In&#x000a0;Vivo</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pereira</surname><given-names>Marie</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="fn1" ref-type="fn">4</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Tai-Di</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref><xref rid="fn1" ref-type="fn">4</xref></contrib><contrib contrib-type="author"><name><surname>Buang</surname><given-names>Norzawani</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Olona</surname><given-names>Antoni</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Ko</surname><given-names>Jeong-Hun</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Prendecki</surname><given-names>Maria</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Costa</surname><given-names>Ana S.H.</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Nikitopoulou</surname><given-names>Efterpi</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Tronci</surname><given-names>Laura</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Pusey</surname><given-names>Charles D.</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Cook</surname><given-names>H. Terence</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>McAdoo</surname><given-names>Stephen P.</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Frezza</surname><given-names>Christian</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Behmoaras</surname><given-names>Jacques</given-names></name><email>jacques.behmoaras@imperial.ac.uk</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="fn2" ref-type="fn">5</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Centre for Inflammatory Disease, Imperial College London, London W12 0NN, UK</aff><aff id="aff2"><label>2</label>Department of Anatomic Pathology, Chang Gung Memorial Hospital, Taoyuan, Taiwan</aff><aff id="aff3"><label>3</label>Medical Research Council Cancer Unit, University of Cambridge, Cambridge CB2 0XZ, UK</aff><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author <email>jacques.behmoaras@imperial.ac.uk</email></corresp><fn id="fn1"><label>4</label><p id="ntpara0010">These authors contributed equally</p></fn><fn id="fn2"><label>5</label><p id="ntpara0015">Lead Contact</p></fn></author-notes><pub-date pub-type="pmc-release"><day>09</day><month>7</month><year>2019</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><day>09</day><month>7</month><year>2019</year></pub-date><pub-date pub-type="epub"><day>09</day><month>7</month><year>2019</year></pub-date><volume>28</volume><issue>2</issue><fpage>498</fpage><lpage>511.e5</lpage><history><date date-type="received"><day>11</day><month>12</month><year>2018</year></date><date date-type="rev-recd"><day>29</day><month>4</month><year>2019</year></date><date date-type="accepted"><day>7</day><month>6</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 The Author(s)</copyright-statement><copyright-year>2019</copyright-year><license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><abstract id="abs0010"><title>Summary</title><p>Iron is an essential metal that fine-tunes the innate immune response by regulating macrophage function, but an integrative view of transcriptional and metabolic responses to iron perturbation in macrophages is lacking. Here, we induced acute iron chelation in primary human macrophages and measured their transcriptional and metabolic responses. Acute iron deprivation causes an anti-proliferative Warburg transcriptome, characterized by an ATF4-dependent signature. Iron-deprived human macrophages show an inhibition of oxidative phosphorylation and a concomitant increase in glycolysis, a large increase in glucose-derived citrate pools associated with lipid droplet accumulation, and modest levels of itaconate production. LPS polarization increases the itaconate:succinate ratio and decreases pro-inflammatory cytokine production. In rats, acute iron deprivation reduces the severity of macrophage-dependent crescentic glomerulonephritis by limiting glomerular cell proliferation and inducing lipid accumulation in the renal cortex. These results suggest that acute iron deprivation has <italic>in&#x000a0;vivo</italic> protective effects mediated by an anti-inflammatory immunometabolic switch in macrophages.</p></abstract><abstract abstract-type="graphical" id="abs0015"><title>Graphical Abstract</title><fig id="undfig1" position="anchor"><graphic xlink:href="fx1"/></fig></abstract><abstract abstract-type="author-highlights" id="abs0020"><title>Highlights</title><p><list list-type="simple" id="ulist0010"><list-item id="u0010"><label>&#x02022;</label><p id="p0010">Acute iron deprivation causes an atypical Warburg effect in human macrophages</p></list-item><list-item id="u0015"><label>&#x02022;</label><p id="p0015">Iron controls citrate and lipid pools and is essential for an intact TCA cycle</p></list-item><list-item id="u0020"><label>&#x02022;</label><p id="p0020">LPS polarization is limited in iron-deprived human macrophages</p></list-item><list-item id="u0025"><label>&#x02022;</label><p id="p0025">Acute iron deprivation reduces the severity of macrophage-driven glomerulonephritis</p></list-item></list></p></abstract><abstract abstract-type="teaser" id="abs0025"><p>Iron is a crucial regulator of cell function, but its role in human macrophage immunometabolism is only partially understood. Pereira et&#x000a0;al. show that acute iron deprivation in human macrophages causes anti-inflammatory immune and metabolic responses, and acute iron deprivation in rats reduces the severity of macrophage-driven renal inflammation.</p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>macrophages</kwd><kwd>iron</kwd><kwd>immunometabolism</kwd><kwd>inflammation</kwd><kwd>mitochondria</kwd><kwd>glomerulonephritis</kwd></kwd-group></article-meta><notes><p id="misc0010">Published: July 9, 2019</p></notes></front><body><sec id="sec1"><title>Introduction</title><p id="p0030">Iron, an essential metal for life, is a crucial regulator of innate immunity&#x000a0;through macrophage function. Considering its vast pleiotropic roles in cellular homeostasis and its preferential enrichment&#x000a0;in proteins belonging to mitochondria and the endoplasmic reticulum (ER; <xref rid="bib4" ref-type="bibr">Andreini et&#x000a0;al., 2018</xref>), iron has a master regulatory role in macrophage metabolism and its crosstalk with immune plasticity. Iron-dependent immunometabolism in macrophages occurs at multiple levels. Iron could be integrated into heme or iron-sulfur (Fe-S) clusters, which in turn are incorporated into specific protein families (hemoproteins and Fe-S cluster&#x000a0;proteins) that orchestrate metabolic and immunological functions in macrophages (<xref rid="bib1" ref-type="bibr">Aerbajinai et&#x000a0;al., 2019</xref>, <xref rid="bib17" ref-type="bibr">Drapier and Hibbs, 1988</xref>, <xref rid="bib63" ref-type="bibr">Soares and Hamza, 2016</xref>, <xref rid="bib76" ref-type="bibr">Tong et&#x000a0;al., 2018</xref>). Furthermore, in its non-heme, Fe<sup>2+</sup> form, iron can govern the activity&#x000a0;of enzymes such as &#x003b1;-ketoglutarate (&#x003b1;KG)-dependent dioxygenases upstream of oxygen sensing and epigenetic modifications (<xref rid="bib40" ref-type="bibr">Loenarz and Schofield, 2008</xref>, <xref rid="bib47" ref-type="bibr">Nakazawa et&#x000a0;al., 2016</xref>) or lipoxygenases responsible for generating bioactive lipid mediators (<xref rid="bib23" ref-type="bibr">Haeggstr&#x000f6;m and Funk, 2011</xref>). Besides its role in promoting immune activation in macrophages, iron is crucial in regulating the fundamental properties of eukaryotic cells such as DNA replication (<xref rid="bib49" ref-type="bibr">Netz et&#x000a0;al., 2011</xref>) and repair (<xref rid="bib60" ref-type="bibr">Rudolf et&#x000a0;al., 2006</xref>), and there is evidence of macrophage iron levels affecting the proliferation of stromal cells (<xref rid="bib58" ref-type="bibr">Recalcati et&#x000a0;al., 2019</xref>).</p><p id="p0035">Macrophages show a sophisticated fine-tuning of intracellular iron availability during bacterial and fungal pathogenicity, a concept recently referred to as innate nutritional immunity (<xref rid="bib5" ref-type="bibr">Andrianaki et&#x000a0;al., 2018</xref>, <xref rid="bib46" ref-type="bibr">Nairz et&#x000a0;al., 2010</xref>, <xref rid="bib50" ref-type="bibr">N&#x000fa;&#x000f1;ez et&#x000a0;al., 2018</xref>). Iron homeostasis affecting macrophage plasticity was also studied in the context of sterile inflammation and cancer. It has been reported that iron overloading in macrophages occurs in human chronic venous leg ulcers and cause an unrestrained pro-inflammatory M1-like phenotype (<xref rid="bib62" ref-type="bibr">Sindrilaru et&#x000a0;al., 2011</xref>). Likewise, increased intracellular iron polarizes the macrophages toward a detrimental pro-inflammatory state in the injured spinal cord (<xref rid="bib36" ref-type="bibr">Kroner et&#x000a0;al., 2014</xref>), and iron-positive microglia and macrophages in chronic active multiple sclerosis lesions are thought to be a source of inflammation that correlates with tissue damage and disease severity (<xref rid="bib20" ref-type="bibr">Gillen et&#x000a0;al., 2018</xref>). In keeping with these findings, in a mouse model of sickle disease, hemolysis and macrophage heme-iron accumulation trigger a proinflammatory phenoytpe in hepatic macrophages (<xref rid="bib78" ref-type="bibr">Vinchi et&#x000a0;al., 2016</xref>). In cancer, iron-loaded tumor-associated macrophages adopt a pro-inflammatory phenotype that can directly kill tumor cells (<xref rid="bib11" ref-type="bibr">Costa da Silva et&#x000a0;al., 2017</xref>), and the usage of iron oxide nanoparticles is an attractive avenue in cancer immunotherapy through the modulation of macrophage activity (<xref rid="bib22" ref-type="bibr">Gu et&#x000a0;al., 2019</xref>, <xref rid="bib84" ref-type="bibr">Zanganeh et&#x000a0;al., 2016</xref>). In summary, the findings from all of the above-mentioned studies converge toward a macrophage polarization profile resulting from prolonged exposure to iron in the tissue microenvironment, correlating with a pro-inflammatory (M1-like) phenotype. Although this phenotype associates with tissue damage during inflammatory disease (<xref rid="bib36" ref-type="bibr">Kroner et&#x000a0;al., 2014</xref>, <xref rid="bib62" ref-type="bibr">Sindrilaru et&#x000a0;al., 2011</xref>, <xref rid="bib78" ref-type="bibr">Vinchi et&#x000a0;al., 2016</xref>), it has been reported to be beneficial in cancer (<xref rid="bib11" ref-type="bibr">Costa da Silva et&#x000a0;al., 2017</xref>, <xref rid="bib84" ref-type="bibr">Zanganeh et&#x000a0;al., 2016</xref>).</p><p id="p0040">Studies aiming to experimentally induce acute changes in cellular iron metabolism during inflammation are scarce. Reducing mitochondrial iron in the heart protects mice against ischemia-reperfusion injury (<xref rid="bib10" ref-type="bibr">Chang et&#x000a0;al., 2016</xref>). In human cell lines, acute iron deprivation results in profound mitochondria-driven metabolic changes, such as marked citrate accumulation followed by lipid synthesis and decreases the protein levels of several Fe-S cluster biogenesis proteins (<xref rid="bib12" ref-type="bibr">Crooks et&#x000a0;al., 2018</xref>, <xref rid="bib76" ref-type="bibr">Tong et&#x000a0;al., 2018</xref>). These studies suggest that acute manipulation of macrophage iron pools could reprogram its metabolism in the inflammatory microenvironment. However, a comprehensive study on the effects of iron manipulation in macrophage metabolism is lacking. Here, we induced acute iron chelation in&#x000a0;primary human macrophages and measured their metabolic&#x000a0;and transcriptional responses by stable isotope tracing and&#x000a0;RNA sequencing (RNA-seq). We show that iron deficiency triggers hypoxia-inducible factor (HIF-1)-glycolysis and interferon (IFN) transcriptional responses, while there is a generalized&#x000a0;downregulation of cell cycle-mitosis and oxidative phosphorylation&#x000a0;(OXPHOS) pathways. We identify ATF4 as an iron-responsive&#x000a0;transcription factor in human macrophages and show iron-dependent modulation of the expression of some of its known targets. These major responses were rescued with short exposure to FeCl<sub>3</sub> following iron chelation. Metabolically, glucose-derived citrate accumulates markedly and induces intracellular lipid droplet formation, and to a lesser extent itaconate synthesis, when macrophages lack iron. This is associated with the inhibition of the tricarboxylic acid (TCA) cycle, partly due to the downregulation of succinate dehydrogenase complex iron sulfur subunit B (SDHB) and the loss of mitochondrial aconitase activity. Consequently, OXPHOS is abolished and glycolysis is enhanced as a result of iron deprivation in human macrophages. Lipopolysaccharide (LPS) polarization of iron-deprived human macrophages shows that while the itaconate:succinate ratio is&#x000a0;increased, the pro-inflammatory cytokines interleukin-1&#x003b2; (IL-1&#x003b2;) and tumor necrosis factor &#x003b1; (TNF-&#x003b1;) are reduced. This suggests that iron chelation restrains LPS polarization, which is further supported by RNA-seq analysis showing the induction of the transforming growth factor &#x003b2; (TGF-&#x003b2;) pathway in LPS-stimulated&#x000a0;iron-deprived macrophages. <italic>In&#x000a0;vivo</italic>, acute iron deprivation&#x000a0;reduces the severity of macrophage-dependent crescentic&#x000a0;glomerulonephritis by limiting glomerular cell proliferation and induces significant lipid droplet accumulation in the renal cortex.</p><p id="p0045">Our study shows that acute iron deprivation results in a profound metabolic remodeling, promoting an atypical Warburg effect with anti-inflammatory properties in human macrophages. We confirm the beneficial effects of iron deprivation <italic>in&#x000a0;vivo</italic> and propose macrophage iron manipulation as a potential therapeutic approach targeting immunometabolism in these cells.</p></sec><sec id="sec2"><title>Results</title><sec id="sec2.1"><title>Acute Iron Chelation Causes an Atypical Warburg Transcriptome in Human Macrophages</title><p id="p0050">In mitochondria, the TCA cycle activity, respiration complexes, and heme biosynthesis are dependent on iron availability and Fe-S cluster biogenesis. Iron chelators with low membrane permeability such as deferoxamine cannot access the mitochondria, whereas deferiprone (DEF; 3-hydroxy-1,2-dimethylpyridin-4-one) is membrane permeable and can enter mitochondria (<xref rid="bib64" ref-type="bibr">Sohn et&#x000a0;al., 2008</xref>). RNA-seq of human macrophages treated with DEF showed a clear transcriptional response. As previously shown for iron chelation by chemical hypoxia mimetics (<xref rid="bib3" ref-type="bibr">An et&#x000a0;al., 1998</xref>, <xref rid="bib56" ref-type="bibr">Peyssonnaux et&#x000a0;al., 2007</xref>), we confirmed a glycolysis-HIF-P53 signature among the significantly upregulated gene families (<xref rid="fig1" ref-type="fig">Figures 1</xref>A and <xref rid="mmc1" ref-type="supplementary-material">S1</xref>). These cells also show an induction of IFN signaling, while cell division-mitosis and OXPHOS were downregulated (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>A). Given the previously established role of iron chelation in pseudohypoxia (<xref rid="bib56" ref-type="bibr">Peyssonnaux et&#x000a0;al., 2007</xref>) and cell division-mitosis (<xref rid="bib38" ref-type="bibr">Le and Richardson, 2002</xref>), these results suggested iron-dependent transcriptomic changes in human macrophages. To further confirm that the transcriptional effects were due to the iron-chelation properties of DEF, human macrophages were treated with DEF, after which FeCl<sub>3</sub> was added for 8 h. qRT-PCR for the most significant genes belonging to glycolysis-HIF, OXPHOS, and cell division-mitosis showed significant rescue of the DEF effect with iron supplementation in some of the transcripts (<xref rid="fig1" ref-type="fig">Figures 1</xref>B and 1C). These results suggested&#x000a0;that the major transcriptomics changes obtained with DEF treatment are due to iron deprivation in human macrophages. Since the results show that acute iron deprivation is&#x000a0;associated with metabolic changes, we next examined how&#x000a0;DEF compares to the well-established lipopolysaccharide&#x000a0;(LPS)-mediated transcriptome characterized by increased glycolysis and attenuated OXPHOS in macrophages (<xref rid="bib33" ref-type="bibr">Kelly and O&#x02019;Neill, 2015</xref>, <xref rid="bib43" ref-type="bibr">Mills et&#x000a0;al., 2016</xref>). Comparative RNA-seq analysis between LPS and DEF-treated human macrophages showed that iron deprivation downregulated activating transcription factor 4 (ATF4)-mediated gene activation (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S1</xref>). This was not present in LPS-treated cells, which showed the upregulation of well-established Toll-like receptor, Janus kinase/signal transducer and activator of transcription (JAK/STAT), and nucleotide-binding oligomerization domain-like (NOD-like) receptor signaling pathways (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S1</xref>). We subsequently confirmed that ATF4 protein levels and the expression of some of its known target genes are dependent on acute changes in iron (<xref rid="fig1" ref-type="fig">Figures 1</xref>D and <xref rid="mmc1" ref-type="supplementary-material">S1</xref>). To confirm the role of ATF4 in a more clinical setting, we examined the acute effects of intravenous iron administration in&#x000a0;patients with stable, non-immune chronic kidney disease (CKD), who were receiving iron therapy as part of their routine clinical&#x000a0;care. Peripheral blood mononuclear cells (PBMCs) were collected before and 120&#x000a0;min following intravenous iron (Ferinject 1&#x02013;1.5 g) infusion, and ATF4 protein levels showed a clear increase following iron transfusion in all of the patients (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>E), confirming its iron-mediated rapid induction.<fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>Acute Iron Deprivation Causes an Atypical Warburg Transcriptome and Mediates an ATF4-Driven Transcriptional Response in Human Macrophages</p><p>(A) Gene set enrichment analysis (GSEA) in upregulated and downregulated transcripts between control (basal) and DEF-treated human macrophages (500&#x000a0;&#x003bc;M, 24 h), measured by RNA-seq (n&#x000a0;= 3 donors; Fc &#x0003e; 1.5; P<sub>adj</sub>&#x000a0;&#x0003c; 0.01).</p><p>(B) Volcano plot from RNA-seq highlighting genes belonging to glycolysis-HIF, cell division, and OXPHOS pathways.</p><p>(C) qRT-PCR for main glycolysis-HIF, cell division, and OXPHOS genes (color-coded) in iron-deprived (DEF, 500&#x000a0;&#x003bc;M, 24 h) and rescued human macrophages with short exposure (8 h) to 200&#x000a0;&#x003bc;M ferric chloride (DEF&#x000a0;+ FeCl<sub>3</sub>); n&#x000a0;= 4&#x02013;9 donors/group.</p><p>(D) ATF4 western blotting in iron-deprived (DEF) and rescued (DEF&#x000a0;+ FeCl<sub>3</sub>) human macrophages from three donors.</p><p>(E) ATF4 western blotting before and after 2&#x000a0;h of intravenous iron transfusion (Ferinject 1&#x02013;1.5 g) in 3 CKD patients&#x02019; PBMCs (see <xref rid="sec4.4" ref-type="sec">Method Details</xref> and <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref> for patient information). <sup>&#x02217;</sup>p&#x000a0;&#x0003c; 0.05, <sup>&#x02217;&#x02217;</sup>p&#x000a0;&#x0003c; 0.01, and <sup>&#x02217;&#x02217;&#x02217;</sup>p&#x000a0;&#x0003c; 0.001 by ANOVA followed by Tukey&#x02019;s multiple comparisons test. <italic>P</italic><sub>adj</sub>, adjusted p value; Fc, fold change. Error bars represent SEM.</p><p>See also <xref rid="mmc1" ref-type="supplementary-material">Figures S1</xref> and <xref rid="mmc1" ref-type="supplementary-material">S2</xref>.</p></caption><graphic xlink:href="gr1"/></fig></p><p id="p0055">Since metabolic consequences of acute iron deprivation and defective Fe-S cluster assembly are similar in human cell lines (<xref rid="bib12" ref-type="bibr">Crooks et&#x000a0;al., 2018</xref>), we next tested an alternative, drug-free method of acute iron deprivation and replenishment in human macrophages. RNA interference for <italic>ISCU</italic>, a primary Fe-S biogenesis scaffold protein known to have a master regulatory role in cellular iron levels, showed comparable transcriptomic responses to DEF (upregulation of glycolysis-HIF-IFN and downregulation of cell-cycle pathways) and the addition of FeCl<sub>3</sub> rescued the majority of the effects (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S2</xref>). Likewise, <italic>ISCU</italic> knockdown resulted in ATF4 downregulation, which was rescued with the addition of FeCl<sub>3</sub> in human macrophages (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S2</xref>).</p></sec><sec id="sec2.2"><title>Acute Iron Chelation Causes a Metabolic Switch in Human Macrophages</title><p id="p0060">Iron deprivation resulted in increased glycolysis-HIF, decreased OXPHOS transcriptome pathways in human macrophages (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>), indicative of a dysregulation of mitochondrial function. This was further supported by the suppression of the gene expression of respiratory chain enzymes containing Fe-S clusters, <italic>NDUFS6</italic> and <italic>SDHB</italic> (also known as the Fe-S subunit of complex II; <xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>C). Since SDHB links the TCA cycle to OXPHOS (<xref rid="bib45" ref-type="bibr">Murphy and O&#x02019;Neill, 2018</xref>), we next investigated the iron-dependent control of its protein levels. SDHB protein levels were found to be controlled by intracellular iron levels, as iron replenishment following deprivation brought the levels of this protein back to its basal state (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>A). As expected, iron-dependent mitochondrial aconitase activity was inhibited by DEF (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>B). Iron replenishment partly restored mitochondrial aconitase activity and induced cytoplasmic aconitase activity in human macrophages (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>B). In agreement with SDHB downregulation and loss of aconitase activity, OXPHOS was nearly totally inhibited following iron deprivation in human macrophages (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>C). To measure the glycolytic rate, we incubated cells with uniformly labeled [U]-<sup>13</sup>C-glucose and assessed&#x000a0;the production of glucose-derived lactate using liquid chromatography-mass spectrometry (LC-MS). In line with the&#x000a0;transcriptional changes, we found a significant increase in the secreted glucose-derived lactate (M+3) with no change in the consumption of glucose levels following DEF treatment (<xref rid="fig2" ref-type="fig">Figures 2</xref>D and 2E). Consistently, extracellular acidification rate (ECAR) was&#x000a0;enhanced in DEF-treated human macrophages (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>F). These results functionally validated the transcriptional analyses&#x000a0;and confirmed that DEF elicits a metabolic switch whereby glycolysis is enhanced and mitochondrial function is suppressed.<fig id="fig2"><label>Figure&#x000a0;2</label><caption><p>Acute Iron Deprivation Abolishes Oxidative Phosphorylation and Increases Aerobic Glycolytic Flux in Human Macrophages</p><p>(A) SDHB western blotting in iron-deprived (DEF) and rescued (DEF&#x000a0;+ FeCl<sub>3</sub>) human macrophages from three donors. DEF (24 h, 500&#x000a0;&#x003bc;M); FeCl<sub>3</sub> (8 h, 200&#x000a0;&#x003bc;M).</p><p>(B) Aconitase activity gel in iron-deprived (DEF) and rescued (DEF&#x000a0;+ FeCl<sub>3</sub>) human macrophages from two donors. m-aconitase, mitochondrial; c-aconitase, cytosolic.</p><p>(C) Oxygen consumption rate (OCR) measurement by extracellular flux analysis in control and DEF-treated human macrophages. Basal and maximal respiration and ATP production are shown at right. R/A, rotenone/antimycin; 2-DG, 2-deoxyglucose; DEF (24 h, 500&#x000a0;&#x003bc;M); n&#x000a0;= 4 donors.</p><p>(D) Intracellular and extracellular lactate (glucose-derived adduct shown at left) isotopologue quantification by LC-MS in iron-deprived (DEF, 500&#x000a0;&#x003bc;M, 24 h) and rescued human macrophages with short exposure to 200&#x000a0;&#x003bc;M ferric chloride (DEF&#x000a0;+ FeCl<sub>3</sub>); n&#x000a0;= 6 donors.</p><p>(E) Extracellular glucose M+6 by LC-MS; n&#x000a0;= 6 donors.</p><p>(F) Extracellular acidification rate (ECAR) measured by extracellular flux analysis. R/A, rotenone/antimycin; 2-DG, 2-deoxyglucose, DEF (24 h, 500&#x000a0;&#x003bc;M); n&#x000a0;= 4 donors.</p><p>Significance tested by t test (C, D, and F) and ANOVA followed by Dunnett&#x02019;s multiple comparisons test (E). ns, non-significant compared to Ctrl. <sup>&#x02217;&#x02217;</sup>p&#x000a0;&#x0003c; 0.01 and <sup>&#x02217;&#x02217;&#x02217;</sup>p&#x000a0;&#x0003c; 0.001. Error bars represent SEM.</p></caption><graphic xlink:href="gr2"/></fig></p></sec><sec id="sec2.3"><title>A Citrate Checkpoint Characterizes Acute Iron Deprivation in Human Macrophages</title><p id="p0065">To gain more insights into metabolic pathways affected by acute iron deprivation and replenishment, we incubated untreated, iron-deprived, and iron-repleted human macrophages with the tracer [U]-<sup>13</sup>C-glucose and assessed its fate in the TCA cycle (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>A). Iron deprivation and replenishment was well tolerated in human macrophages (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S3</xref>). We observed a striking increase in citrate levels upon DEF treatment (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>B). The isotopologue distribution analysis (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>A) revealed that the increased intracellular citrate pools were predominantly glucose derived (<xref rid="fig3" ref-type="fig">Figures 3</xref>B and <xref rid="mmc1" ref-type="supplementary-material">S3</xref>). Glucose-derived citrate was partly converted to aconitate and itaconate (<xref rid="fig3" ref-type="fig">Figures 3</xref>A, 3B, and <xref rid="mmc1" ref-type="supplementary-material">S3</xref>), but in relatively modest quantities, which is consistent with the inhibition of the iron-dependent mitochondrial aconitase activity (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>B). Metabolites derived from the TCA cycle activity, such as M+2 glutamate and glutathione (GSH), were decreased, while M+2 malate remained unchanged (<xref rid="mmc1" ref-type="supplementary-material">Figures S3</xref> and <xref rid="mmc1" ref-type="supplementary-material">S4</xref>). This was also the case for the extracellular glutamate, reflected by a reduction in M+2 glutamate (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S4</xref>). These results suggested an inhibition of the TCA cycle between aconitate and &#x003b1;KG. Furthermore, since nitric oxide synthases (NOSs) are heme-dependent enzymes responsible for nitric oxide generation from the oxidation of <sc>l</sc>-arginine to citrulline (<xref rid="bib48" ref-type="bibr">Nathan and Xie, 1994</xref>), iron chelation showed an effect on cellular and extracellular arginine and citrulline pools in human macrophages (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S4</xref>).<fig id="fig3"><label>Figure&#x000a0;3</label><caption><p>A Citrate Checkpoint Characterizes Iron-Deprived Human Macrophages</p><p>(A) Diagram of uniformly labeled [U]-<sup>13</sup>C-glucose catabolism, highlighting the TCA cycle metabolites and their expected glucose-derived <sup>13</sup>C atoms.</p><p>(B) Stacked isotopologues measured by LC-MS shown for citrate, aconitate, itaconate, and glutamate in iron-deprived (DEF, 500&#x000a0;&#x003bc;M, 24 h) and rescued human macrophages with short exposure (8 h) to 200&#x000a0;&#x003bc;M ferric chloride (DEF&#x000a0;+ FeCl<sub>3</sub>); n&#x000a0;= 6 donors.</p><p>(C) Vehicle, DEF-treated, or concomitant DEF and FeCl<sub>3</sub>-treated human macrophages stained for oil red O. The results are representative of n&#x000a0;= 4 donors.</p><p>(D) Summary of the TCA cycle changes due to iron deprivation in human macrophages. Citrate accumulation resulting from aconitase (ACO) inhibition and SDHB downregulation and the fate of citrate-derived metabolites are illustrated. Dashed circle represents inhibited TCA cycle activity. &#x003b1;KG, &#x003b1;-ketoglutarate.</p><p>Scale bars, 40&#x000a0;&#x003bc;m.</p><p>See also <xref rid="mmc1" ref-type="supplementary-material">Figures S3</xref> and <xref rid="mmc1" ref-type="supplementary-material">S4</xref>.</p></caption><graphic xlink:href="gr3"/></fig></p><p id="p0070">Citrate is an important checkpoint metabolite in immunometabolism, critically positioned at the crosstalk between glucose catabolism, fatty acid synthesis, and oxidation (<xref rid="bib74" ref-type="bibr">Tong and Rouault, 2007</xref>, <xref rid="bib82" ref-type="bibr">Williams and O&#x02019;Neill, 2018</xref>). We next hypothesized that marked citrate accumulation following acute iron deprivation could result in lipid droplet accumulation. In line with this hypothesis, DEF-treated human macrophages exhibited a striking increase in lipid droplet accumulation, which was diminished by co-incubation of DEF with FeCl<sub>3</sub> (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>C). Lipid accumulation was similarly reduced when the fatty acid synthase (FASN) inhibitor cerulenin was used together with DEF treatment (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S4</xref>), suggesting that <italic>de novo</italic> synthesis is engaged in iron-depleted macrophages.</p><p id="p0075">In summary, the metabolic reprogramming due to iron deprivation results in marked citrate accumulation, which partly translates into aconitate and itaconate production together with lipid droplet accumulation (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>D). Oxidative phosphorylation is inhibited and &#x003b1;KG-derived metabolites show a decrease, suggesting overall diminished activity of the TCA cycle. This causes a compensatory increase in aerobic glycolysis with the subsequent production and secretion of lactate (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>D).</p></sec><sec id="sec2.4"><title>Acute Iron Deprivation and Pro-inflammatory Macrophage Polarization</title><p id="p0080">To find out how this specific iron-deficient macrophage phenotype undergoes the classical pro-inflammatory activation, we polarized DEF-treated human macrophages with LPS stimulation and measured IL-1&#x003b2; and TNF-&#x003b1; production. The results showed a reduction in secreted factors in iron-chelated macrophages (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>A). We then performed a time course analysis of LPS treatment in DEF-treated macrophages and measured 88 metabolites by LC-MS, including citrate, aconitate, itaconate, and succinate (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>). We first confirmed the truncated TCA cycle in LPS-stimulated iron-deprived macrophages with increased citrate (and citrate:succinate ratio) and aconitate and decreased &#x003b1;KG and glutamate levels (<xref rid="fig4" ref-type="fig">Figures 4</xref>B, 4C, and <xref rid="mmc1" ref-type="supplementary-material">S5</xref>). Itaconate production is further augmented in DEF-treated human macrophages, and the itaconate:succinate ratio was increased at 24&#x000a0;h (<xref rid="fig4" ref-type="fig">Figures 4</xref>B and 4C), which is indicative of overall anti-inflammatory metabolic switching (<xref rid="bib45" ref-type="bibr">Murphy and O&#x02019;Neill, 2018</xref>). <italic>IRG1</italic> mRNA levels did not show an apparent DEF effect, suggesting that the effects of iron deprivation on itaconate levels are likely to be mediated by changes in metabolic fluxes, rather than by the transcriptional regulation of <italic>IRG1</italic> (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S5</xref>). Comparative RNA-seq analysis between LPS and LPS&#x000a0;+ DEF-treated macrophages during early activation (3 h) confirmed the results obtained with Ctrl versus DEF comparison (i.e., increased glycolysis, IFN-&#x003b3; signaling, decreased OXPHOS, and DNA replication; <xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S5</xref>). Iron-depleted macrophages stimulated with LPS showed upregulation of the TGF-&#x003b2; signaling pathway, which is associated with increases&#x000a0;in <italic>TGFB1</italic>, <italic>VEGFA</italic>, <italic>CTGF</italic>, <italic>CXCL12</italic>, <italic>IL10</italic>, and <italic>IL1RN</italic> expression levels (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S5</xref>). Considering the anti-inflammatory role of itaconate (<xref rid="bib7" ref-type="bibr">Bambouskova et&#x000a0;al., 2018</xref>, <xref rid="bib44" ref-type="bibr">Mills et&#x000a0;al., 2018</xref>), these results suggest that acute iron chelation limits the classical macrophage polarization by increasing the itaconate:succinate ratio, decreasing secreted IL-1&#x003b2;, and TNF-&#x003b1;, and promoting the early induction of the TGF-&#x003b2; signaling pathway.<fig id="fig4"><label>Figure&#x000a0;4</label><caption><p>Acute Iron Chelation Limits the Pro-inflammatory Macrophage Polarization</p><p>(A) IL-1&#x003b2; and TNF-&#x003b1; production in iron-deprived human macrophages (500&#x000a0;&#x003bc;M, 24 h), following LPS treatment (100&#x000a0;ng/mL, 24 h; LPS&#x000a0;+ DEF); n&#x000a0;= 7 donors.</p><p>(B) LC-MS for citrate, itaconate, and succinate in basal and DEF-treated macrophages (500&#x000a0;&#x003bc;M, 24 h) throughout an LPS (100&#x000a0;ng/mL) time course; n&#x000a0;= 4 donors.</p><p>(C) Itaconate:succinate and citrate:succinate ratios at 24 h; n&#x000a0;= 4 donors.</p><p>Significance tested by ANOVA followed by Tukey&#x02019;s multiple comparisons test (A) and t test (B and C). <sup>&#x02217;</sup>p&#x000a0;&#x0003c; 0.05, <sup>&#x02217;&#x02217;</sup>p&#x000a0;&#x0003c; 0.01, and <sup>&#x02217;&#x02217;&#x02217;</sup>p&#x000a0;&#x0003c; 0.001. Error bars represent&#x000a0;SEM.</p><p>See also <xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S5</xref>.</p></caption><graphic xlink:href="gr4"/></fig><fig id="fig5"><label>Figure&#x000a0;5</label><caption><p>Acute Iron Chelation and Time Course Metabolomics in LPS-Stimulated Human Macrophages</p><p>Heatmap for LC-MS analysis of 88 metabolites in basal (Ctrl), LPS treated (1, 3, 8, and 24 h) and LPS&#x000a0;+ DEF-treated human macrophages; DEF treatment is 500&#x000a0;&#x003bc;M, 24 h; n&#x000a0;= 4 donors.</p></caption><graphic xlink:href="gr5"/></fig></p></sec><sec id="sec2.5"><title>Acute Iron Deprivation Is Preventive in Glomerulonephritis and Induces <italic>De Novo</italic> Lipogenesis</title><p id="p0085">To investigate the pathophysiological significance of acute iron deprivation in a macrophage-dependent inflammatory disease model, crescentic glomerulonephritis was induced in the Wistar Kyoto rats treated either with vehicle or DEF (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>A). Oral DEF treatment markedly lowered the levels of proteinuria during the entire disease course (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>B) and ameliorated glomerular morphology (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>C). The glomeruli of the DEF-treated group had a substantially reduced fibrin score and crescent formation as well as decreased glomerular size (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>D). Since the WKY nephrotoxic nephritis (NTN) model depends on the infiltration and activation of monocytes and macrophages (<xref rid="bib8" ref-type="bibr">Behmoaras et&#x000a0;al., 2010</xref>), we performed ED-1 (rat CD68) staining and showed that DEF significantly decreased the number of monocytes and macrophages in the glomeruli (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S6</xref>). We then checked whether the lipid accumulation as a result of iron deprivation was conserved <italic>in&#x000a0;vivo</italic> and found increased oil red O staining in DEF-treated rat glomeruli and renal cortex following NTN (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>E), suggesting that the citrate-derived <italic>de novo</italic> fatty acid synthesis occurs during acute iron deprivation in experimental crescentic glomerulonephritis. Furthermore, since iron deprivation caused a downregulation of cell cycle-mitosis pathways measured by RNA-seq (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>A), we measured intraglomerular cell proliferation and found decreased proliferating glomerular cell nuclear antigen (PCNA) in DEF-treated animals following the induction of NTN (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>F).<fig id="fig6"><label>Figure&#x000a0;6</label><caption><p>Acute Iron Deprivation Protects against Crescentic Glomerulonephritis and Induces <italic>De Novo</italic> Lipid Accumulation</p><p>(A) Experimental design.</p><p>(B) Amount of urinary protein at different time points during the course of NTN; n=3 or 4 rats/group.</p><p>(C) PAS staining showing representative glomerular morphology of the vehicle (left) and the DEF (right) groups.</p><p>(D) Glomerular fibrin score, percentage of glomeruli with crescents, and glomerular size in vehicle and DEF-treated rats; n&#x000a0;= 3 or 4 rats/group.</p><p>(E) Nephritic glomeruli of vehicle- or DEF-treated rats showing oil red O<sup>+</sup> glomerular and tubular cells in the DEF group.</p><p>(F) PCNA staining showing proliferating cells in nephritic glomeruli; number of nuclear PCNA(+) cells in the glomeruli (bottom); n&#x000a0;= 3 or 4 rats/group.</p><p>(G) Experimental design for the therapeutic experiment.</p><p>(H) Amount of urinary protein levels at different time points during the course of NTN; n&#x000a0;= 4 or 5 rats/group.</p><p>(I) PAS staining showing representative glomerular morphology of the vehicle (left) and DEF (right) groups.</p><p>(J) Glomerular fibrin score, percentage of glomeruli with crescents, and glomerular size in vehicle- and DEF-treated rats; n&#x000a0;= 4 or 5 rats/group.</p><p><sup>&#x02217;</sup>p&#x000a0;&#x0003c; 0.05, <sup>&#x02217;&#x02217;</sup>p&#x000a0;&#x0003c; 0.01, and <sup>&#x02217;&#x02217;&#x02217;</sup>p&#x000a0;&#x0003c; 0.001 by t test. Scale bars, 40&#x000a0;&#x003bc;m. Error bars represent SEM.</p><p>See also <xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S6</xref>.</p></caption><graphic xlink:href="gr6"/></fig></p><p id="p0090">To assess whether DEF has therapeutic effects after the onset of glomerulonephritis, rats were treated with or without DEF from day 4 following the induction of NTN, which corresponds to the onset of renal damage and proteinuria. The rats were then sacrificed on day 10, at the peak of glomerular inflammation (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>G). Notably, the progression of proteinuria at day 10 was reversed in rats treated with DEF when compared to either the treated group on day 7 or their control counterparts at day 10 (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>H). The glomerular morphology of DEF-treated rats at day 10 showed improved features when compared to vehicle-treated rats (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>I), which was also accompanied by reduced fibrin score and crescent formation together with decreased glomerular size (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>J). Monocyte/macrophage infiltration was significantly decreased by DEF (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S6</xref>), and acute iron deprivation by DEF resulted in ameliorated renal function (i.e., reduced creatinine and blood urea nitrogen) associated with reduced intraglomerular cell proliferation (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S6</xref>). DEF treatment did not alter erythropoiesis as hemoglobin levels were not&#x000a0;significantly altered (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S6</xref>). In addition to its therapeutic effects <italic>in&#x000a0;vivo</italic>, DEF reduced superoxide production in the NTN-susceptible WKY rat bone marrow-derived macrophages (BMDMs) and its antioxidant properties were confirmed in a cell-free superoxide production system (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S6</xref>). In summary, <italic>in&#x000a0;vivo</italic> iron chelation in macrophage-dependent renal inflammation is accompanied by metabolic and transcriptomic changes (<italic>de novo</italic> lipid accumulation, anti-proliferative responses) that are conserved <italic>in&#x000a0;vitro</italic> cultured human macrophages.</p></sec></sec><sec id="sec3"><title>Discussion</title><p id="p0095">Iron serves as a prosthetic group for proteins orchestrating immunometabolic responses at multiple levels in macrophages. For instance, mammalian complex I hosts as many as eight Fe-S clusters (<xref rid="bib79" ref-type="bibr">Vinothkumar et&#x000a0;al., 2014</xref>), allowing optimal electron transfer during OXPHOS and maintaining the balance between the generation of reactive oxygen species (ROS) and ATP production (<xref rid="bib43" ref-type="bibr">Mills et&#x000a0;al., 2016</xref>). Furthermore, non-mitochondrial ROS production, an essential feature of macrophage-driven immune phagocytic responses, is partly mediated by NOX2 (CYBB), which uses heme-iron for superoxide generation (<xref rid="bib67" ref-type="bibr">Sumimoto, 2008</xref>). In this study, we showed that iron deprivation caused an induction of glycolysis-HIF and a repression of OXPHOS pathways in human macrophages. Dendritic cells and macrophages, when stimulated with pro-inflammatory stimuli, decrease OXPHOS with a simultaneous upregulation of glycolysis and activity in the pentose phosphate pathway (<xref rid="bib35" ref-type="bibr">Krawczyk et&#x000a0;al., 2010</xref>, <xref rid="bib43" ref-type="bibr">Mills et&#x000a0;al., 2016</xref>, <xref rid="bib71" ref-type="bibr">Tannahill et&#x000a0;al., 2013</xref>). Although iron deprivation and pro-inflammatory M1-type macrophage stimulation share the same metabolic switch, the underlying mechanisms are likely to differ. The inhibition of OXPHOS is explained by nitric oxide-mediated nitrosylation of mitochondrial Fe-S clusters in LPS-stimulated murine macrophages (<xref rid="bib17" ref-type="bibr">Drapier and Hibbs, 1988</xref>, <xref rid="bib18" ref-type="bibr">Everts et&#x000a0;al., 2012</xref>). Instead, iron deprivation directly affects the expression and protein levels of respiratory chain Fe-S enzymes such as <italic>NDUFS6</italic> and <italic>SDHB</italic>. It causes the loss of OXPHOS and ATP production, partly by reducing SDHB levels in conjunction with the inhibition of mitochondrial aconitase activity. The rapid increase in SDHB levels following iron replenishment suggests the existence of an iron-responsive element in <italic>SDHB</italic> mRNA, which was previously reported in <italic>Drosophila</italic> (<xref rid="bib34" ref-type="bibr">Kohler et&#x000a0;al., 1995</xref>). Furthermore, SDHB deletion was associated with reduced IL-1&#x003b2; and HIF-1&#x003b1; in LPS-stimulated macrophages (<xref rid="bib43" ref-type="bibr">Mills et&#x000a0;al., 2016</xref>), although LPS stimulation itself was shown to diminish SDHB protein levels in RAW264.7 cells (<xref rid="bib76" ref-type="bibr">Tong et&#x000a0;al., 2018</xref>). Considering the large-scale suppression of Fe-S cluster biogenesis proteins in response to TLR4 activation in murine cell lines (<xref rid="bib76" ref-type="bibr">Tong et&#x000a0;al., 2018</xref>) and the previously described iron-sequestration phenotype in M1 human macrophages (<xref rid="bib57" ref-type="bibr">Recalcati et&#x000a0;al., 2010</xref>), one could speculate that mitochondrial&#x000a0;iron deprivation, M1 activation, and ISCU small interfering RNA (siRNA) or mutagenesis share in the common inhibition of OXPHOS and a concomitant increase in aerobic glycolysis in macrophages.</p><p id="p0100">DEF is an orally active Food and Drug Administration (FDA)-approved iron chelator that preferentially binds to ferric iron (Fe<sup>3+</sup>) in a 3:1 configuration and is used as alternative or complementary to deferoxamine treatment in hemoglobinopathies characterized by iron overload (<xref rid="bib27" ref-type="bibr">Hider and Hoffbrand, 2018</xref>). DEF can enter the mitochondria and shuttle iron between subcellular compartments (<xref rid="bib64" ref-type="bibr">Sohn et&#x000a0;al., 2008</xref>). Because of its low affinity to iron, DEF is less likely to cause iron depletion, which we also confirmed by measuring DEF-treated mitochondrial and cytosolic iron in human macrophages (data not shown). The ability of DEF to chelate mitochondrial iron and to make it available for other cellular compartments (<xref rid="bib31" ref-type="bibr">Kakhlon et&#x000a0;al., 2008</xref>) has therapeutic benefit for disorders such as Friedreich ataxia characterized by altered mitochondrial Fe-S cluster biogenesis (<xref rid="bib52" ref-type="bibr">Pandolfo and Hausmann, 2013</xref>). More generally, mitochondrial iron handling is central to regulating cellular and systemic homeostasis (<xref rid="bib55" ref-type="bibr">Paul et&#x000a0;al., 2017</xref>). In this context, the distinct properties of DEF make this drug ideal for studying the metabolic consequences arising from mitochondrial iron imbalances rather than measuring the indirect effects of extracellular iron chelation obtained by using deferoxamine. Iron imbalances between mitochondria&#x000a0;and cytosol can have broad pathological consequences in cancer through altered immunometabolism (<xref rid="bib39" ref-type="bibr">Li et&#x000a0;al., 2018</xref>), and the genetic deficiencies of mitochondria-related genes (<italic>FH</italic>, <italic>PINK1</italic>) are likely to trigger dysregulation of the mitochondria-cytosol iron balance, which is associated with the Warburg effect and HIF signature in cancer (<xref rid="bib39" ref-type="bibr">Li et&#x000a0;al., 2018</xref>, <xref rid="bib75" ref-type="bibr">Tong et&#x000a0;al., 2011</xref>, <xref rid="bib77" ref-type="bibr">Tyrakis et&#x000a0;al., 2017</xref>). We observed a macrophage pseudohypoxia transcriptome (i.e., HIF response in the presence of oxygen; <xref rid="bib61" ref-type="bibr">Selak et&#x000a0;al., 2005</xref>, <xref rid="bib71" ref-type="bibr">Tannahill et&#x000a0;al., 2013</xref>) with DEF treatment, which was previously described in LPS-stimulated macrophages (<xref rid="bib71" ref-type="bibr">Tannahill et&#x000a0;al., 2013</xref>). One limitation of our study is that the use of FeCl<sub>3</sub> for iron replenishment <italic>in&#x000a0;vitro</italic> does not mimic exposure to heme-iron, which occurs <italic>in&#x000a0;vivo</italic> through the phagocytosis of red blood cells by macrophages due to hemorrhage, as reported in spinal cord injury (<xref rid="bib36" ref-type="bibr">Kroner et&#x000a0;al., 2014</xref>). In hemolytic diseases, which are characterized by the enhanced release of hemoglobin and heme into the circulation, heme-iron loading of reticulo-endothelial system macrophages changes their activation (<xref rid="bib78" ref-type="bibr">Vinchi et&#x000a0;al., 2016</xref>). Nonetheless, macrophages can also be exposed to non-heme iron released from dying cells, and it should also be noted that the pro-oxidant properties FeCl<sub>3</sub> may exacerbate the oxidative stress and trigger the ATF4 response.</p><p id="p0105">One major transcriptional response that was specific to DEF treatment was ATF4 downregulation. Given the induction of this transcription factor in oxidative and ER stress responses (<xref rid="bib2" ref-type="bibr">Ameri and Harris, 2008</xref>) and during heme-dependent erythroid differentiation (<xref rid="bib68" ref-type="bibr">Suragani et&#x000a0;al., 2012</xref>), this result confirms the antioxidant properties of DEF and its effect on superoxide neutralization. Furthermore, ATF4 reprograms CD4<sup>+</sup> T&#x000a0;cell metabolism and immune response (<xref rid="bib83" ref-type="bibr">Yang et&#x000a0;al., 2018</xref>), and it is therefore conceivable that it has a similar role in human macrophages, especially given its effect on glutathione levels (<xref rid="bib83" ref-type="bibr">Yang et&#x000a0;al., 2018</xref>). Another distinct feature of acute iron deprivation was its modest itaconate production when compared to LPS-stimulated human macrophages, which produce large amounts of this anti-inflammatory metabolite (<xref rid="bib44" ref-type="bibr">Mills et&#x000a0;al., 2018</xref>, <xref rid="bib53" ref-type="bibr">Papathanassiu et&#x000a0;al., 2017</xref>). The limited itaconate production with iron deprivation could come from the type 1 interferon response affecting IRG1 gene expression (<xref rid="bib44" ref-type="bibr">Mills et&#x000a0;al., 2018</xref>). Considering the anti-inflammatory (<xref rid="bib37" ref-type="bibr">Lampropoulou et&#x000a0;al., 2016</xref>, <xref rid="bib44" ref-type="bibr">Mills et&#x000a0;al., 2018</xref>) and pro-tumorigenic&#x000a0;(<xref rid="bib80" ref-type="bibr">Weiss et&#x000a0;al., 2018</xref>) effects of itaconate, it may contribute to the broadly anti-inflammatory macrophage phenotype we observe following iron deprivation. LPS stimulation augments itaconate production in iron-deprived macrophages and increases the itaconate:succinate ratio, while decreasing IL-1&#x003b2; and TNF-&#x003b1; secretion and promoting the TGF-&#x003b2; signaling pathway. These results indicate that acute iron chelation limits classic LPS polarization partly through the immunomodulatory properties of itaconate. A recent addition to the latter is the inhibitory&#x000a0;effects of itaconate during immune tolerance (<xref rid="bib15" ref-type="bibr">Dominguez-Andres et&#x000a0;al., 2019</xref>). Furthermore, itaconate is bactericidal, which is in line with the previously established antibacterial properties of iron chelators (<xref rid="bib72" ref-type="bibr">Thompson et&#x000a0;al., 2012</xref>).</p><p id="p0110">Acute iron deprivation in human macrophages resulted in a robust citrate accumulation, which could be primarily attributed to aconitase inhibition. Mitochondrial and cytosolic aconitases catalyze the interconversion of citrate and isocitrate, and their activities are affected by cellular iron and oxidative levels and the activity of Fe-S biogenesis (<xref rid="bib74" ref-type="bibr">Tong and Rouault, 2007</xref>). Citrate can be transported across the inner mitochondrial membrane via the tricarboxylate carrier, and once in the cytosol, it is the substrate of ATP-citrate lyase, which generates acetyl-coenzyme A (CoA), the building block of cholesterol and the fatty acids. <italic>De novo</italic> fatty acid synthesis is the hallmark of LPS-stimulated dendritic cells (<xref rid="bib19" ref-type="bibr">Everts et&#x000a0;al., 2014</xref>) and macrophages (<xref rid="bib9" ref-type="bibr">Carroll et&#x000a0;al., 2018</xref>). Fatty acid oxidation has been associated with pro-inflammatory macrophage activation (<xref rid="bib24" ref-type="bibr">Hall et&#x000a0;al., 2013</xref>, <xref rid="bib25" ref-type="bibr">Hall et&#x000a0;al., 2018</xref>), which highlights the complexity of lipid metabolism and&#x000a0;the possible master-regulatory role of citrate in fine-tuning&#x000a0;context-dependent macrophage responses. Here, we found that macrophages accumulate lipid droplets as a result of iron deprivation. In contrast with what was observed with TNF/IFN stimulation (<xref rid="bib30" ref-type="bibr">Infantino et&#x000a0;al., 2014</xref>), the marked citrate accumulation was not associated with a pro-inflammatory signal, suggesting that citrate pools are preferentially used for lipogenesis, causing steatosis in macrophages and nephritic kidneys. Citrate and iron metabolism are intimately linked as citrate can chelate divalent cations such as Fe<sup>2+</sup> and is proposed to be one of the carriers of non-transferrin-bound iron (<xref rid="bib21" ref-type="bibr">Grootveld et&#x000a0;al., 1989</xref>). It can also inhibit succinate oxidation (<xref rid="bib28" ref-type="bibr">Hillar et&#x000a0;al., 1975</xref>). Systemically, elevated citrate levels have been linked to increased hepcidin mRNA expression in primary hepatocytes and <italic>in&#x000a0;vivo</italic> (<xref rid="bib13" ref-type="bibr">da Silva et&#x000a0;al., 2017</xref>), suggesting the existence of a citrate-iron regulatory feedback loop in macrophages. Citrate has also been linked to IFN-&#x003b3; production through the acetylation of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in T&#x000a0;cells (<xref rid="bib6" ref-type="bibr">Balmer et&#x000a0;al., 2016</xref>), a mechanism that could explain enhanced IFN response in iron-deprived human macrophages.</p><p id="p0115">Studies on macrophage polarization following the manipulation of intracellular iron levels by different means has resulted in contrasting results, presumably because of the different model systems and the possible existence of a critical concentration of intracellular iron that likely drives the polarization (<xref rid="bib58" ref-type="bibr">Recalcati et&#x000a0;al., 2019</xref>). While treatment with hepcidin resulted in the attenuation of the inflammatory response in LPS-treated macrophages (<xref rid="bib14" ref-type="bibr">De Domenico et&#x000a0;al., 2010</xref>), dietary iron restriction rendered spleen macrophages pro-inflammatory following sublethal LPS injection in mice (<xref rid="bib51" ref-type="bibr">Pagani et&#x000a0;al., 2011</xref>). No obvious changes in BMDM polarization markers were observed following the conditional deletion of ferroportin from the myeloid lineage (<xref rid="bib58" ref-type="bibr">Recalcati et&#x000a0;al., 2019</xref>). More recently, and in accordance with&#x000a0;our findings, the knock down of glia maturation factor-&#x003b3; (GMFG) in macrophages was shown to cause an iron-deficiency response and M2 macrophage polarization associated with reduced mitochondrial respiration chain components, ISCU, and basal oxygen consumption and an increased HIF response (<xref rid="bib1" ref-type="bibr">Aerbajinai et&#x000a0;al., 2019</xref>). Likewise, treatment with iron led to M1 polarization in mice BMDMs (<xref rid="bib26" ref-type="bibr">Handa et&#x000a0;al., 2019</xref>).</p><p id="p0120">The acute iron chelation in experimental glomerulonephritis resulted in <italic>de novo</italic> lipid synthesis but ameliorated the renal outcome. Considering that defective fatty acid oxidation was linked to fibrosis in CKD (<xref rid="bib32" ref-type="bibr">Kang et&#x000a0;al., 2015</xref>), these results argue in favor of a possible transient beneficial role of <italic>de novo</italic> lipogenesis in inflammation, as observed by others (<xref rid="bib54" ref-type="bibr">Papazyan et&#x000a0;al., 2016</xref>, <xref rid="bib65" ref-type="bibr">Solinas et&#x000a0;al., 2015</xref>). The systemic use of DEF in macrophage-dependent inflammatory disease should take into account the extent of iron loading in macrophages residing in different tissues. In fact, depending on tissue-dependent variation in ferroportin levels (<xref rid="bib16" ref-type="bibr">Drakesmith et&#x000a0;al., 2015</xref>), the macrophage iron content is likely to differ in different organs, and systemic iron deprivation may not have the same effect on infiltrating and tissue-resident macrophages.</p><p id="p0125">When compared with the well-known LPS/Toll-like receptor 4 (TLR4)-induced Warburg effect in macrophages, iron deprivation-mediated immunometabolism could be considered atypical (i.e., a sterile Warburg effect devoid of pro-inflammatory programming), suggesting the different degrees of this phenomenon in the spectrum model of macrophage plasticity. In summary, immunometabolic changes derived from acute iron deprivation in macrophages could be considered a future therapeutic angle in macrophage-dependent inflammatory disease.</p></sec><sec id="sec4"><title>STAR&#x02605;Methods</title><sec id="sec4.1"><title>Key Resources Table</title><p id="p0130"><table-wrap position="float" id="undtbl1"><table frame="hsides" rules="groups"><thead><tr><th>REAGENT or RESOURCE</th><th>SOURCE</th><th>IDENTIFIER</th></tr></thead><tbody><tr><td colspan="3"><bold>Antibodies</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>ATF-4 (D4B8) Rabbit mAb</td><td>Cell Signaling Technologies</td><td>Cat# 11815</td></tr><tr><td>Anti-SDHB</td><td>Abcam</td><td>Cat# ab14714</td></tr><tr><td>Anti- ACTB</td><td>Santa Cruz</td><td>Cat# sc-47778</td></tr><tr><td>Anti-rat ED1</td><td>Bio-Rad</td><td>Cat# MCA341R</td></tr><tr><td>anti-PCNA</td><td>Abcam</td><td>Cat# ab29</td></tr><tr><td>Polyclonal Rabbit Anti-mouse immunoglobulins/HRP</td><td>DAKO</td><td>Cat# P0260</td></tr><tr><td>Polyclonal Swine Anti-rabbit immunoglobulins/HRP</td><td>DAKO</td><td>Cat# P0217</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Chemicals, Peptides, and Recombinant Proteins</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>Recombinant Human M-CSF</td><td>PeproTech</td><td>Cat# AF-300-25</td></tr><tr><td>Oil-Red-O</td><td>Sigma</td><td>Cat# O0625</td></tr><tr><td>Haematoxylin</td><td>Sigma</td><td>Cat# MHS16</td></tr><tr><td>Iron(III) chloride (FeCl<sub>3</sub>)</td><td>Sigma</td><td>Cat# 451649</td></tr><tr><td>Deferiprone (DEF)</td><td>Sigma</td><td>Cat# 379409</td></tr><tr><td>2-deoxyglucose (2-DG)</td><td>Sigma</td><td>Cat# D6134</td></tr><tr><td>NADP</td><td>Sigma</td><td>Cat# N5755</td></tr><tr><td>cis-aconitic acid</td><td>Sigma</td><td>Cat# A3412</td></tr><tr><td>MTT</td><td>Sigma</td><td>Cat# M5655</td></tr><tr><td>phenazine methosulfate</td><td>Sigma</td><td>Cat# P9625</td></tr><tr><td>isocitrate dehydrogenase</td><td>Sigma</td><td>Cat# I5036</td></tr><tr><td>Cerulenin</td><td>Sigma</td><td>Cat# C2389</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Critical Commercial Assays</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>Seahorse XF Cell Mito Stress Test Kit</td><td>Agilent Technologies</td><td>Cat #103015-100</td></tr><tr><td>RNeasy mini kit</td><td>QIAGEN</td><td>Cat# 74106</td></tr><tr><td>RNase-free DNase Kit</td><td>QIAGEN</td><td>Cat# 79254</td></tr><tr><td>NEBNext Ultra II Directional RNA Library Prep kit</td><td>NEB</td><td>Cat# E7760</td></tr><tr><td>iScript cDNA Synthesis Kit</td><td>Bio-Rad</td><td>Cat# 170-8891</td></tr><tr><td>Brilliant II SYBR Green QPCR Master Mix</td><td>Agilent</td><td>Cat# 600828</td></tr><tr><td>Pierce BCA Protein Assay Kit</td><td>Thermo Fisher Scientific</td><td>Cat# 23225</td></tr><tr><td>IL-1&#x003b2; ELISA</td><td>Invitrogen</td><td>Cat# 88-7261-88</td></tr><tr><td>TNF&#x003b1; ELISA</td><td>Invitrogen</td><td>Cat# 88-7346-88</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Deposited Data</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>RNA-sequencing data</td><td>This paper</td><td>GEO accession number <ext-link ext-link-type="uri" xlink:href="ncbi-geo:GSE128885" id="intref0010">GSE128885</ext-link></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Oligonucleotides</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td><xref rid="mmc1" ref-type="supplementary-material">Table S2</xref></td><td>This paper</td><td>N/A</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Software and Algorithms</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>picard (v.2.6.0)</td><td>N/A</td><td><ext-link ext-link-type="uri" xlink:href="https://broadinstitute.github.io/picard/" id="intref0015">https://broadinstitute.github.io/picard/</ext-link></td></tr><tr><td>edgeR (v.3.22.3)</td><td>(<xref rid="bib59" ref-type="bibr">Robinson et&#x000a0;al., 2010</xref>)</td><td><ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/bioc/html/edgeR.html" id="intref0020">https://bioconductor.org/packages/release/bioc/html/edgeR.html</ext-link></td></tr><tr><td>DESeq2 (v.1.14.1)</td><td>(<xref rid="bib41" ref-type="bibr">Love et&#x000a0;al., 2014</xref>)</td><td><ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/bioc/html/DESeq2.html" id="intref0025">https://bioconductor.org/packages/release/bioc/html/DESeq2.html</ext-link></td></tr><tr><td>pcaExplorer (v.2.6.0)</td><td>N/A</td><td><ext-link ext-link-type="uri" xlink:href="https://github.com/federicomarini/pcaExplorer" id="intref0030">https://github.com/federicomarini/pcaExplorer</ext-link></td></tr><tr><td>pheatmap (v 1.0.10)</td><td>N/A</td><td><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/pheatmap/index.html" id="intref0035">https://cran.r-project.org/web/packages/pheatmap/index.html</ext-link></td></tr><tr><td>ggplot2 (v.3.0.0)</td><td>(<xref rid="bib81" ref-type="bibr">Wickham, 2016</xref>)</td><td><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/ggplot2/index.html" id="intref0040">https://cran.r-project.org/web/packages/ggplot2/index.html</ext-link></td></tr><tr><td>R/Bioconductor environment (v.3.4.4)</td><td>N/A</td><td><ext-link ext-link-type="uri" xlink:href="http://www.R-project.org/" id="intref0045">http://www.R-project.org/</ext-link></td></tr><tr><td>Gene Set Enrichment Analysis (GSEA) (v5.2)</td><td>(<xref rid="bib66" ref-type="bibr">Subramanian et&#x000a0;al., 2005</xref>)</td><td><ext-link ext-link-type="uri" xlink:href="http://software.broadinstitute.org/gsea/index.jsp" id="intref0050">http://software.broadinstitute.org/gsea/index.jsp</ext-link></td></tr><tr><td>STRING database</td><td>(<xref rid="bib69" ref-type="bibr">Szklarczyk et&#x000a0;al., 2015</xref>)</td><td><ext-link ext-link-type="uri" xlink:href="https://string-db.org/" id="intref0055">https://string-db.org/</ext-link></td></tr><tr><td>GraphPad prism (v 7.02)</td><td>GraphPad Software</td><td>N/A</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Other</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>RPMI 1640 medium</td><td>Life Technologies</td><td>Cat# 11879020</td></tr><tr><td>Fetal calf serum (FCS)</td><td>Labtech International</td><td>Cat# FB-1001</td></tr><tr><td>Hanks&#x02019; Balanced Salt Solution (HBSS)</td><td>Life Technologies</td><td>Cat# 14170112</td></tr><tr><td>Histopaque</td><td>Sigma</td><td>Cat# 1077</td></tr><tr><td>Seahorse XF RPMI medium</td><td>Agilent Technologies</td><td>Cat # 103576-100</td></tr><tr><td>SILAC medium</td><td>SILAC medium</td><td>Cat# A2494201</td></tr><tr><td>L-glutamine</td><td>Thermo Fisher Scientific</td><td>Cat# 25030081</td></tr><tr><td>L-Arginine</td><td>Sigma</td><td>Cat# A8094</td></tr><tr><td>L-Lysine</td><td>Sigma</td><td>Cat# L8662</td></tr><tr><td>D-Glucose U-13C, 99%</td><td>Cambridge isotope laboratories</td><td>Cat# CLM-1396</td></tr><tr><td>AMPure XP Beads</td><td>Beckman Coulter</td><td>Cat# A63880</td></tr><tr><td>SuperSignal West Femto Chemiluminescent Substrate</td><td>Thermo Fisher Scientific</td><td>Cat# 34580</td></tr><tr><td>TWEEN 20</td><td>Sigma</td><td>Cat# P1379</td></tr><tr><td>ON-TARGETplus SMARTpool - Human</td><td>Dharmacon</td><td>Cat# L-HUMAN-XX</td></tr><tr><td>DharmaFECT 1 Transfection Reagent</td><td>Dharmacon</td><td>Cat# T-2001</td></tr><tr><td>OPTIMEM</td><td>Thermo Fisher Scientific</td><td>Cat# 11058021</td></tr></tbody></table></table-wrap></p></sec><sec id="sec4.2"><title>Lead Contact and Materials Availability</title><p id="p0135">Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Jacques Behmoaras (<ext-link ext-link-type="uri" xlink:href="mailto:Jacques.behmoaras@imperial.ac.uk" id="intref0060">Jacques.behmoaras@imperial.ac.uk</ext-link>).</p></sec><sec id="sec4.3"><title>Experimental Model and Subject Details</title><sec id="sec4.3.1"><title>Rats</title><p id="p0140">WKY (male, 16-weeks old, WKY/NCrl) rats used for NTN experiments were purchased from Charles River UK. All rats were used straight from the source by housing them until the appropriate experimental age. All procedures were performed in accordance to institutional guidelines and procedures approved by the UK Home Office (United Kingdom Animals Scientific Procedures Act, 1986).</p></sec><sec id="sec4.3.2"><title>CKD patients</title><p id="p0145">Acute effects of intravenous iron administration were investigated in patients with stable non-immune chronic kidney disease, not requiring renal replacement therapy. Samples were provided after written informed consent, and in accordance with NHS Health Research authority approval. A summary of patient characteristics is provided in <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>. All patients were clinically well, without evidence of acute infection or incurrent illness at the time of iron administration, and none had received intravenous iron or blood transfusion in the preceding three months.</p></sec></sec><sec id="sec4.4"><title>Method Details</title><sec id="sec4.4.1"><title>Isolation of macrophages and PBMCs</title><p id="p0150">Human monocyte-derived macrophages (hMDMs) were differentiated from buffy cones from healthy donors using gradient separation (Histopaque 1077, Sigma) and adhesion purification. Following Histopaque separation, peripheral blood mononuclear cells were re-suspended in RPMI 1640 (Life Technologies), and monocytes were purified by adherence for 1&#x02009;hour at 37&#x000b0;C, 5% CO<sub>2</sub>. The monolayer was washed three times with HBSS to remove non-adherent cells, and monocytes were matured for 5&#x000a0;days in RPMI containing 100&#x02009;ng/mL macrophage colony-stimulating factor (M-CSF, PeproTech, London, UK) and 10% fetal calf serum (Labtech International). For the deferiprone (DEF) treatment, macrophages were treated with 500&#x000a0;&#x003bc;M DEF (Sigma), in full culture media overnight. Cells were then prepared for either RNA-sequencing or LC-MS experiments using D-Glucose U-<sup>13</sup>C. For rescue experiments involving the addition of FeCl<sub>3</sub>, macrophages deprived from iron with over-night DEF treatment, were treated with FeCl<sub>3</sub> (200&#x000a0;&#x003bc;M, Sigma) for 8&#x000a0;hours, after which the cells were isolated and used in different assays. Lipopolysaccharide (LPS, Sigma) treatment of hMDMs was used either for RNA-seq or LC-MS experiments.</p><p id="p0155">CKD patients received intravenous iron, as Ferinject (ferric carboxymaltose, 50mg/mL) at a total dose of 1-1.5g by slow infusion over 30&#x000a0;minutes. Peripheral blood was drawn in EDTA immediately prior and 120&#x000a0;min following iron infusion, and processed immediately. Peripheral blood mononuclear cells (PBMCs) were isolated by Histopaque (1077, Sigma) density gradient centrifugation and used for ATF4 Western Blotting before and after iron infusion.</p></sec><sec id="sec4.4.2"><title>Metabolic extracellular flux analysis</title><p id="p0160">Real-time measurements of OCR and ECAR were performed using a Seahorse XF96 Extracellular Flux Analyzer (Agilent Technologies). hMDMs cultured for 5&#x000a0;days in presence of RPMI containing M-CSF (100&#x02009;ng/ml) and FCS (10%) were washed and incubated with DEF. Cells were then washed, re-suspended using the non-enzymatic cell dissociation buffer (Sigma) and 5&#x000a0;&#x000d7; 10<sup>5</sup> hMDMs were seeded as a monolayer in a 96-well microplate containing Seahorse XF RPMI medium (Agilent Technologies). The different metabolic drugs were injected (oligomycin 1&#x003bc;M, FCCP 2&#x003bc;M, rotenone/antimycin 1&#x003bc;M, 2-DG 50mM) during real-time measurements of OCR and ECAR, using the Seahorse XF Cell Mito Stress Test Kit (Agilent Technologies). Basal respiration was calculated as the last measurement before addition of oligomycin &#x02013; non mitochondrial respiration (minimum rate measurement after Rot/AntA). Maximal respiration is shown as the maximum rate measurement after addition of FCCP &#x02013; non mitochondrial respiration. Estimated ATP production designates the last measurement before addition of oligomycin &#x02013; minimum rate after oligomycin. Glycolysis refers to ECAR values before the addition of oligomycin.</p></sec><sec id="sec4.4.3"><title>Stable isotope tracing by liquid chromatography-mass spectrometry (LC-MS)</title><p id="p0165">For stable isotope tracing, human macrophages (treated or left as basal) were incubated for 8 hours with SILAC medium lacking glucose and phenol red (GIBCO) with addition of L-glutamine (0.5&#x000a0;mM), arginine (200&#x000a0;mg/L), lysine (40&#x000a0;mg/L) and uniformly labeled glucose (2 g/L D-Glucose U-<sup>13</sup>C, 99%, Cambridge isotope laboratories). Cells were then washed three times with PBS and 200&#x003bc;l of extraction buffer (50% LC-MS grade methanol and 30% acetonitrile, 20% ultrapure water) was added per 10<sup>6</sup> cells. Following 15&#x000a0;min incubation in dry ice, the cells were scraped off and kept under vigorous shaking for 15&#x000a0;min at 4&#x000b0;C, and left for 1 hour incubation at &#x02212;20&#x000b0;C. Following centrifugation, the supernatant was stored at &#x02212;80&#x000b0;C until further analysis. For the cell supernatant analysis, the&#x000a0;same procedure was performed in supernatant obtained from 10<sup>6</sup> cells. For the steady-state metabolomics analysis, cells were stimulated with LPS and DEF or left unstimulated (basal) at indicated times, followed by the same extraction procedure described above.</p><p id="p0170">Samples were randomized in order to avoid bias due to machine drift and processed blindly. LC-MS analysis was performed using a Q Exactive mass spectrometer (Thermo Fisher Scientific) coupled to a Dionex U3000&#x000a0;UHPLC system. The liquid chromatography system was fitted with a Sequant ZIC-pHILIC column (150&#x000a0;mm &#x000d7; 2.1&#x000a0;mm) and guard column (20&#x000a0;mm &#x000d7; 2.1&#x000a0;mm) from Merck Millipore (Germany) and temperature maintained at 40&#x000b0;C. The mobile phase was composed of 20&#x000a0;mM ammonium carbonate and 0.1% ammonium hydroxide in water (solvent A), and acetonitrile (solvent B). The flow rate was set at 200&#x000a0;&#x003bc;L/min with the gradient as described previously (<xref rid="bib42" ref-type="bibr">Mackay et&#x000a0;al., 2015</xref>). The mass spectrometer was operated in full MS and polarity switching mode. The acquired spectra were analyzed using XCalibur Qual Browser and XCalibur Quan Browser software (Thermo Fisher Scientific). To generate the heatmap, the raw data were normalized by total ion count and missing values were replaced by half of the minimum value of each metabolite. Heatmap was then generated with the heatmap.2 function of the gplots package by creating z-score values and using default clustering methods.</p></sec><sec id="sec4.4.4"><title>RNA extraction and library preparation</title><p id="p0175">Total RNA was extracted from hMDMs using Trizol (Invitrogen) and RNeasy mini kit (QIAGEN) according to manufacturer&#x02019;s instructions, with an additional purification step by on-column DNase treatment using the RNase-free DNase Kit (QIAGEN) to ensure elimination of any genomic DNA. The integrity and quantity of total RNA was determined using a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific) and Agilent 2100 Bioanalyzer (Agilent Technologies). 500&#x02009;ng of total RNA was used to generate RNA-seq libraries using NEBNext Ultra II Directional RNA Library Prep kit from Illumina, according to the manufacturer&#x02019;s instructions. Briefly, RNA was purified and fragmented with poly-T oligo-attached magnetic beads, using two rounds of purification followed by the first and second cDNA strand synthesis. Next, cDNA 3&#x02032; ends were adenylated and adapters ligated followed by 11 cycles of library amplification. The libraries were size selected using AMPure XP Beads (Beckman Coulter), subsequently purified and their quality was checked using Agilent 2100 Bioanalyzer. Samples were randomized to avoid batch effects and multiplexed libraries were run on a single lane (8 samples/lane) of the HiSeq 2500 platform (Illumina) to generate 100bp paired-end reads.</p></sec><sec id="sec4.4.5"><title>Bioinformatics</title><p id="p0180">An average depth of 52&#x000a0;M reads per sample was achieved. Sequencing adapters were removed using Trimmomatic (v.0.36) and the reads quality was checked using FastQC (v.0.11.2) before and after trimming. Reads were aligned to the human genome (GRCh38.primary_assembly.genome.fa; annotation: gencode.v25.annotation.gtf) using tophat2 package (v.2.1.0: -b2-sensitive,&#x02013;library-type&#x000a0;fr-firststrand). An average mapping percentage of 97.1% was achieved and the average number of properly paired reads&#x000a0;was 51.4&#x000a0;M (&#x0223c;95%). Mapping quality, read distribution, gene body coverage, GC content and rRNA contamination, were checked using picard (v.2.6.0) software. Gene level read counts were computed using HT-Seq-count (v.0.6.1) with strict &#x0201c;-m intersection-strict&#x0201d; mode. Genes with less than 10 aligned reads across all samples were filtered out as lowly expressed genes, resulting in 15,732 expressed genes. Differential gene expression analysis between groups was performed using DESeq2 (v.1.14.1) and significantly differentially expressed genes were reported using a cut-of fold-change (FC) at 1.5 and below 1% Benjamini-Hochberg (BH) adjusted <italic>P</italic>-value (<italic>P</italic><sub>adj</sub>). Unsupervised hierarchical clustering and principal component analysis (PCA) were performed using pcaExplorer (v.2.6.0, <ext-link ext-link-type="uri" xlink:href="https://github.com/federicomarini/pcaExplorer" id="intref0065">https://github.com/federicomarini/pcaExplorer</ext-link>) and pheatmap (v 1.0.10, <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/pheatmap/index.html" id="intref0070">https://cran.r-project.org/web/packages/pheatmap/index.html</ext-link>) packages respectively. Volcano plots of differentially expressed genes were generated using ggplot2 (v.3.0.0, <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/ggplot2/index.html" id="intref0075">https://cran.r-project.org/web/packages/ggplot2/index.html</ext-link>) package. All raw RNA-seq data processing steps were performed in Cx1 high-performance cluster computing environment, Imperial College&#x000a0;London. Further analyses were conducted in R/Bioconductor environment v.3.4.4 (<ext-link ext-link-type="uri" xlink:href="http://www.R-project.org/" id="intref0080">http://www.R-project.org/</ext-link>).</p><p id="p0185">Gene Set Enrichment Analysis (GSEA v5.2, <ext-link ext-link-type="uri" xlink:href="http://software.broadinstitute.org/gsea/index.jsp" id="intref0085">http://software.broadinstitute.org/gsea/index.jsp</ext-link>) was utilized to identify potential specific biological pathway or signature enrichment between different treatment groups. All gene sets with an FDR less than 0.25 were considered as statistically significant. For gene ontology (GO) analysis, a cut-of (FC &#x0003e; 1.5, P<sub>adj</sub>&#x000a0;&#x0003c; 0.01) was applied to the differentially expressed genes and the resulting transcripts were entered to STRING database (<ext-link ext-link-type="uri" xlink:href="https://string-db.org/" id="intref0090">https://string-db.org/</ext-link>) to interrogate protein-protein&#x000a0;interactions together with pathway enrichement.</p></sec><sec id="sec4.4.6"><title>Quantitative RT-PCR</title><p id="p0190">Total RNA was extracted from human macrophages using the TRIzol reagent (Invitrogen) according to the manufacturer&#x02019;s instructions, and cDNA was synthesized using iScript cDNA Synthesis Kit (Bio-Rad). A total of 10&#x000a0;ng cDNA for each sample was used. All quantitative RT-PCRs were performed on a ViaA 7 Real-Time PCR System (Life Technologies) using Brilliant II SYBR Green QPCR Master Mix (Agilent), followed by ViiA 7 RUO Software for the determination of Ct values. Results were analyzed using the comparative Ct method, and each sample was normalized to the reference mRNA level of <italic>HPRT</italic> gene, to account for any potential cDNA loading differences.</p></sec><sec id="sec4.4.7"><title>Western blotting</title><p id="p0195">Human macrophages were lysed in Laemmli sample buffer supplemented with protease inhibitors and resolved by SDS-PAGE, transferred into PVDF membranes, and subjected to immunoblotting with the primary antibodies against ATF4 (Cell Signaling Technologies), SDHB (Abcam), ACTB (Santa Cruz) and secondary detection antibodies. The probed proteins were detected using SuperSignal West Femto Chemiluminescent Substrate (Thermo Fisher Scientific Inc., Rockford, IL).</p></sec><sec id="sec4.4.8"><title>RNA interference</title><p id="p0200">hMDMs were re-plated in six-well plates (1&#x000a0;&#x000d7; 10<sup>6</sup> cells per well) in RPMI (Invitrogen) overnight and transfected with siGENOME SMARTpool for human <italic>ISCU</italic> (100&#x02009;nM, Dharmacon SMART pool) or non-targeting siRNA pool as the scrambled control siRNA using Dharmafect 1 (1:50, Dharmacon) as a transfection reagent in OPTIMEM medium (Invitrogen). Following 8&#x02009;h incubation with OPTIMEM media containing either <italic>ISCU</italic> or non-targeting siRNA, cells were washed and further cultured for 48&#x02009;h in presence of RPMI media containing M-CSF and FCS. Iron supplementation was achieved by culturing the macrophages for an additional 8 hours in presence of FeCl<sub>3</sub>.</p></sec><sec id="sec4.4.9"><title>ELISA</title><p id="p0205">Detection of human IL-1&#x003b2; and TNF&#x003b1; (Invitrogen) in hMDM culture supernatants at indicated conditions, were performed by sandwich ELISA, using technical duplicates, following the manufacturer&#x02019;s recommendations. Light absorbance was measured using Multiscan Ascent (Thernofisher).</p></sec><sec id="sec4.4.10"><title>Nephrotoxic Nephritis and immunohistochemistry</title><p id="p0210">Male WKY rats (Charles River UK) weighing 300-360&#x000a0;g were used for the induction of nephrotoxic nephritis (NTN). Nephrotoxic serum was prepared in rabbits and NTN was induced by intravenous injection as previously described (<xref rid="bib70" ref-type="bibr">Tam et&#x000a0;al., 1999</xref>). Groups of animals were given either DEF (200&#x000a0;mg/kg/day in 0.1% carboxymethyl cellulose by oral gavage) or vehicle only. Rats were individually housed in metabolic cages overnight for urine collection, and urinary protein levels were determined by sulphosalicylic acid method. Serum blood urea nitrogen and creatinine were measured using an Abbott Architect c8000 clinical chemistry analyzer. Paraffin-embedded kidneys were sectioned for periodic acid-Schiff (PAS) staining. Fibrin deposition was scored as the number of glomerular quadrants involved from &#x02018;0&#x02019; (absence of fibrin) to &#x02018;4+&#x02019; (fibrin occupying more than &#x000be; of the glomerulus) in 50 consecutive glomeruli. Crescent formation was recorded as presence/absence in 100 consecutive glomeruli and presented as percentage of glomeruli with crescents. Immunohistochemistry was performed and developed with EnVision+ System-HRP (Dako) using mouse anti-rat ED1 (Bio-Rad) and anti-PCNA [PC10] (Abcam) antibodies. Pictures of 20 consecutive glomeruli from each ED1 stained slide were taken with a QImaging Retiga 2000R Scientific CCD Camera, using Image-Pro&#x000ae; Plus Version 7.0 software. The size of the glomeruli and ED1 stained area in glomeruli were measured using ImageJ software. The number of anti-PCNA stained cells in 20 consecutive glomeruli were counted. All histological and immunohistochemical analyses were performed in a blinded manner.</p></sec><sec id="sec4.4.11"><title>Oil-red-o staining</title><p id="p0215">Optimal Cutting Temperature compound embedded frozen rat kidneys were sectioned at 5 microns thickness and 10% formalin fixed for 10&#x000a0;min at room temperature prior to staining. hMDMs cultured in slide-chambers were treated with DEF alone (500&#x000a0;&#x003bc;M) or together with FeCl<sub>3</sub> (200&#x000a0;&#x003bc;M) or cerulenin (20&#x000a0;&#x003bc;M) for 48 hours. The cells were fixed with 10% formalin at 4&#x000b0;C. Kidney sections and hMDMs were stained for lipids by Oil-Red-O (0.5% Oil red O dye in 60% isopropanol; Sigma) and counterstained with Haematoxylin (Sigma). Pictures were obtained by light microscopy using a Leica DM6 B upright microscope and a Leica DFC7000&#x000a0;T camera.</p></sec><sec id="sec4.4.12"><title>Aconitase in-gel assay</title><p id="p0220">In-gel aconitase activities were measured as described previously (<xref rid="bib29" ref-type="bibr">Holmes-Hampton et&#x000a0;al., 2018</xref>, <xref rid="bib73" ref-type="bibr">Tong and Rouault, 2006</xref>). Aconitase&#x000a0;activity gels are composed of a separating gel containing 8% acrylamide (132&#x000a0;mM Tris base, 132&#x000a0;mM borate, 3.6mM citrate) and a 4% acrylamide (67&#x000a0;mM Tris base, 67&#x000a0;mM borate, 3.6&#x000a0;mM citrate) stacking gel. The running buffer contains 25&#x000a0;mM Tris pH 8.3, 192&#x000a0;mM glycine, and 3.6&#x000a0;mM citrate. Protein concentration of macrophage lysates was measured by using the Pierce BCA Protein Assay Kit and the sample buffer contained 25&#x000a0;mM Tris-Cl, pH 8.0, 10% glycerol, and 0.025% bromophenol blue. Electrophoresis was carried out at 180 V, 4&#x000b0;C, for 2 hours. Aconitase activities were assayed by incubating the gel in the dark at 37&#x000b0;C in 100&#x000a0;mM Tris (pH 8.0), 1&#x000a0;mM NADP, 2.5&#x000a0;mM cis-aconitic acid, 5&#x000a0;mM MgCl<sub>2</sub>, 1.2&#x000a0;mM MTT, 0.3&#x000a0;mM phenazine methosulfate, and 5&#x000a0;U/ml isocitrate dehydrogenase (Sigma).</p></sec></sec><sec id="sec4.5"><title>Quantification and Statistical Analysis</title><p id="p0225">Data are presented as mean &#x000b1; s.e.m. and analyzed using GraphPad Prism software (version 7.02; GraphPad). One-way ANOVA (followed&#x000a0;by Dunnett&#x02019; or Tukey&#x02019;s multiple comparison tests) and Student&#x02019;s t test were performed unless otherwise stated. Differences in percentage of fold change following <italic>ISCU</italic> siRNA knockdown were tested for significance using a one-sample-t test. In uniformly labeled [U]-13C-glucose experiments, one-way ANOVA was applied to test for significance in glucose-derived isotopologues.</p></sec><sec sec-type="data-availability" id="sec4.6"><title>Data and Code Availability</title><p id="p0255">The accession number for the RNA-sequencing data reported in this paper is GEO accession number GEO: <ext-link ext-link-type="uri" xlink:href="ncbi-geo:GSE128885" id="interref0100">GSE128885</ext-link>.</p></sec></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Aerbajinai</surname><given-names>W.</given-names></name><name><surname>Ghosh</surname><given-names>M.C.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Kumkhaek</surname><given-names>C.</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Chin</surname><given-names>K.</given-names></name><name><surname>Rouault</surname><given-names>T.A.</given-names></name><name><surname>Rodgers</surname><given-names>G.P.</given-names></name></person-group><article-title>Glia maturation factor-&#x003b3; regulates murine macrophage iron metabolism and M2 polarization through mitochondrial ROS</article-title><source>Blood Adv.</source><volume>3</volume><year>2019</year><fpage>1211</fpage><lpage>1225</lpage><pub-id pub-id-type="pmid">30971398</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Ameri</surname><given-names>K.</given-names></name><name><surname>Harris</surname><given-names>A.L.</given-names></name></person-group><article-title>Activating transcription factor 4</article-title><source>Int. J. Biochem. Cell Biol.</source><volume>40</volume><year>2008</year><fpage>14</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">17466566</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>An</surname><given-names>W.G.</given-names></name><name><surname>Kanekal</surname><given-names>M.</given-names></name><name><surname>Simon</surname><given-names>M.C.</given-names></name><name><surname>Maltepe</surname><given-names>E.</given-names></name><name><surname>Blagosklonny</surname><given-names>M.V.</given-names></name><name><surname>Neckers</surname><given-names>L.M.</given-names></name></person-group><article-title>Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha</article-title><source>Nature</source><volume>392</volume><year>1998</year><fpage>405</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">9537326</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Andreini</surname><given-names>C.</given-names></name><name><surname>Putignano</surname><given-names>V.</given-names></name><name><surname>Rosato</surname><given-names>A.</given-names></name><name><surname>Banci</surname><given-names>L.</given-names></name></person-group><article-title>The human iron-proteome</article-title><source>Metallomics</source><volume>10</volume><year>2018</year><fpage>1223</fpage><lpage>1231</lpage><pub-id pub-id-type="pmid">30095136</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Andrianaki</surname><given-names>A.M.</given-names></name><name><surname>Kyrmizi</surname><given-names>I.</given-names></name><name><surname>Thanopoulou</surname><given-names>K.</given-names></name><name><surname>Baldin</surname><given-names>C.</given-names></name><name><surname>Drakos</surname><given-names>E.</given-names></name><name><surname>Soliman</surname><given-names>S.S.M.</given-names></name><name><surname>Shetty</surname><given-names>A.C.</given-names></name><name><surname>McCracken</surname><given-names>C.</given-names></name><name><surname>Akoumianaki</surname><given-names>T.</given-names></name><name><surname>Stylianou</surname><given-names>K.</given-names></name></person-group><article-title>Iron restriction inside macrophages regulates pulmonary host defense against Rhizopus species</article-title><source>Nat. Commun.</source><volume>9</volume><year>2018</year><fpage>3333</fpage><pub-id pub-id-type="pmid">30127354</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Balmer</surname><given-names>M.L.</given-names></name><name><surname>Ma</surname><given-names>E.H.</given-names></name><name><surname>Bantug</surname><given-names>G.R.</given-names></name><name><surname>Gr&#x000e4;hlert</surname><given-names>J.</given-names></name><name><surname>Pfister</surname><given-names>S.</given-names></name><name><surname>Glatter</surname><given-names>T.</given-names></name><name><surname>Jauch</surname><given-names>A.</given-names></name><name><surname>Dimeloe</surname><given-names>S.</given-names></name><name><surname>Slack</surname><given-names>E.</given-names></name><name><surname>Dehio</surname><given-names>P.</given-names></name></person-group><article-title>Memory CD8(+) T Cells Require Increased Concentrations of Acetate Induced by Stress for Optimal Function</article-title><source>Immunity</source><volume>44</volume><year>2016</year><fpage>1312</fpage><lpage>1324</lpage><pub-id pub-id-type="pmid">27212436</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Bambouskova</surname><given-names>M.</given-names></name><name><surname>Gorvel</surname><given-names>L.</given-names></name><name><surname>Lampropoulou</surname><given-names>V.</given-names></name><name><surname>Sergushichev</surname><given-names>A.</given-names></name><name><surname>Loginicheva</surname><given-names>E.</given-names></name><name><surname>Johnson</surname><given-names>K.</given-names></name><name><surname>Korenfeld</surname><given-names>D.</given-names></name><name><surname>Mathyer</surname><given-names>M.E.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Huang</surname><given-names>L.H.</given-names></name></person-group><article-title>Electrophilic properties of itaconate and derivatives regulate the I&#x003ba;B&#x003b6;-ATF3 inflammatory axis</article-title><source>Nature</source><volume>556</volume><year>2018</year><fpage>501</fpage><lpage>504</lpage><pub-id pub-id-type="pmid">29670287</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Behmoaras</surname><given-names>J.</given-names></name><name><surname>Smith</surname><given-names>J.</given-names></name><name><surname>D&#x02019;Souza</surname><given-names>Z.</given-names></name><name><surname>Bhangal</surname><given-names>G.</given-names></name><name><surname>Chawanasuntoropoj</surname><given-names>R.</given-names></name><name><surname>Tam</surname><given-names>F.W.</given-names></name><name><surname>Pusey</surname><given-names>C.D.</given-names></name><name><surname>Aitman</surname><given-names>T.J.</given-names></name><name><surname>Cook</surname><given-names>H.T.</given-names></name></person-group><article-title>Genetic loci modulate macrophage activity and glomerular damage in experimental glomerulonephritis</article-title><source>J.&#x000a0;Am. Soc. Nephrol.</source><volume>21</volume><year>2010</year><fpage>1136</fpage><lpage>1144</lpage><pub-id pub-id-type="pmid">20488952</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Carroll</surname><given-names>R.G.</given-names></name><name><surname>Zas&#x00142;ona</surname><given-names>Z.</given-names></name><name><surname>Galv&#x000e1;n-Pe&#x000f1;a</surname><given-names>S.</given-names></name><name><surname>Koppe</surname><given-names>E.L.</given-names></name><name><surname>S&#x000e9;vin</surname><given-names>D.C.</given-names></name><name><surname>Angiari</surname><given-names>S.</given-names></name><name><surname>Triantafilou</surname><given-names>M.</given-names></name><name><surname>Triantafilou</surname><given-names>K.</given-names></name><name><surname>Modis</surname><given-names>L.K.</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>L.A.</given-names></name></person-group><article-title>An unexpected link between fatty acid synthase and cholesterol synthesis in proinflammatory macrophage activation</article-title><source>J.&#x000a0;Biol. Chem.</source><volume>293</volume><year>2018</year><fpage>5509</fpage><lpage>5521</lpage><pub-id pub-id-type="pmid">29463677</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>H.C.</given-names></name><name><surname>Wu</surname><given-names>R.</given-names></name><name><surname>Shang</surname><given-names>M.</given-names></name><name><surname>Sato</surname><given-names>T.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Shapiro</surname><given-names>J.S.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Thakur</surname><given-names>A.</given-names></name><name><surname>Sawicki</surname><given-names>K.T.</given-names></name><name><surname>Prasad</surname><given-names>S.V.</given-names></name><name><surname>Ardehali</surname><given-names>H.</given-names></name></person-group><article-title>Reduction in mitochondrial iron alleviates cardiac damage during injury</article-title><source>EMBO Mol. Med.</source><volume>8</volume><year>2016</year><fpage>247</fpage><lpage>267</lpage><pub-id pub-id-type="pmid">26896449</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Costa da Silva</surname><given-names>M.</given-names></name><name><surname>Breckwoldt</surname><given-names>M.O.</given-names></name><name><surname>Vinchi</surname><given-names>F.</given-names></name><name><surname>Correia</surname><given-names>M.P.</given-names></name><name><surname>Stojanovic</surname><given-names>A.</given-names></name><name><surname>Thielmann</surname><given-names>C.M.</given-names></name><name><surname>Meister</surname><given-names>M.</given-names></name><name><surname>Muley</surname><given-names>T.</given-names></name><name><surname>Warth</surname><given-names>A.</given-names></name><name><surname>Platten</surname><given-names>M.</given-names></name></person-group><article-title>Iron Induces Anti-tumor Activity in Tumor-Associated Macrophages</article-title><source>Front. Immunol.</source><volume>8</volume><year>2017</year><fpage>1479</fpage><pub-id pub-id-type="pmid">29167669</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Crooks</surname><given-names>D.R.</given-names></name><name><surname>Maio</surname><given-names>N.</given-names></name><name><surname>Lane</surname><given-names>A.N.</given-names></name><name><surname>Jarnik</surname><given-names>M.</given-names></name><name><surname>Higashi</surname><given-names>R.M.</given-names></name><name><surname>Haller</surname><given-names>R.G.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Fan</surname><given-names>T.W.</given-names></name><name><surname>Linehan</surname><given-names>W.M.</given-names></name><name><surname>Rouault</surname><given-names>T.A.</given-names></name></person-group><article-title>Acute loss of iron-sulfur clusters results in metabolic reprogramming and generation of lipid droplets in mammalian cells</article-title><source>J.&#x000a0;Biol. Chem.</source><volume>293</volume><year>2018</year><fpage>8297</fpage><lpage>8311</lpage><pub-id pub-id-type="pmid">29523684</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>da Silva</surname><given-names>A.R.</given-names></name><name><surname>Neves</surname><given-names>J.</given-names></name><name><surname>Mleczko-Sanecka</surname><given-names>K.</given-names></name><name><surname>Tandon</surname><given-names>A.</given-names></name><name><surname>Sauer</surname><given-names>S.W.</given-names></name><name><surname>Hentze</surname><given-names>M.W.</given-names></name><name><surname>Muckenthaler</surname><given-names>M.U.</given-names></name></person-group><article-title>Cellular citrate levels establish a regulatory link between energy metabolism and the hepatic iron hormone hepcidin</article-title><source>J.&#x000a0;Mol. Med. (Berl.)</source><volume>95</volume><year>2017</year><fpage>851</fpage><lpage>860</lpage><pub-id pub-id-type="pmid">28585096</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>De Domenico</surname><given-names>I.</given-names></name><name><surname>Zhang</surname><given-names>T.Y.</given-names></name><name><surname>Koening</surname><given-names>C.L.</given-names></name><name><surname>Branch</surname><given-names>R.W.</given-names></name><name><surname>London</surname><given-names>N.</given-names></name><name><surname>Lo</surname><given-names>E.</given-names></name><name><surname>Daynes</surname><given-names>R.A.</given-names></name><name><surname>Kushner</surname><given-names>J.P.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Ward</surname><given-names>D.M.</given-names></name><name><surname>Kaplan</surname><given-names>J.</given-names></name></person-group><article-title>Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice</article-title><source>J.&#x000a0;Clin. Invest.</source><volume>120</volume><year>2010</year><fpage>2395</fpage><lpage>2405</lpage><pub-id pub-id-type="pmid">20530874</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Dominguez-Andres</surname><given-names>J.</given-names></name><name><surname>Novakovic</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Scicluna</surname><given-names>B.P.</given-names></name><name><surname>Gresnigt</surname><given-names>M.S.</given-names></name><name><surname>Arts</surname><given-names>R.J.W.</given-names></name><name><surname>Oosting</surname><given-names>M.</given-names></name><name><surname>Moorlag</surname><given-names>S.</given-names></name><name><surname>Groh</surname><given-names>L.A.</given-names></name><name><surname>Zwaag</surname><given-names>J.</given-names></name></person-group><article-title>The Itaconate Pathway Is a Central Regulatory Node Linking Innate Immune Tolerance and Trained Immunity</article-title><source>Cell Metab.</source><volume>29</volume><year>2019</year><fpage>211</fpage><lpage>220.e5</lpage><pub-id pub-id-type="pmid">30293776</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Drakesmith</surname><given-names>H.</given-names></name><name><surname>Nemeth</surname><given-names>E.</given-names></name><name><surname>Ganz</surname><given-names>T.</given-names></name></person-group><article-title>Ironing out ferroportin</article-title><source>Cell Metab.</source><volume>22</volume><year>2015</year><fpage>777</fpage><lpage>787</lpage><pub-id pub-id-type="pmid">26437604</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Drapier</surname><given-names>J.C.</given-names></name><name><surname>Hibbs</surname><given-names>J.B.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Differentiation of murine macrophages&#x000a0;to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells</article-title><source>J.&#x000a0;Immunol.</source><volume>140</volume><year>1988</year><fpage>2829</fpage><lpage>2838</lpage><pub-id pub-id-type="pmid">2451695</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Everts</surname><given-names>B.</given-names></name><name><surname>Amiel</surname><given-names>E.</given-names></name><name><surname>van der Windt</surname><given-names>G.J.</given-names></name><name><surname>Freitas</surname><given-names>T.C.</given-names></name><name><surname>Chott</surname><given-names>R.</given-names></name><name><surname>Yarasheski</surname><given-names>K.E.</given-names></name><name><surname>Pearce</surname><given-names>E.L.</given-names></name><name><surname>Pearce</surname><given-names>E.J.</given-names></name></person-group><article-title>Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells</article-title><source>Blood</source><volume>120</volume><year>2012</year><fpage>1422</fpage><lpage>1431</lpage><pub-id pub-id-type="pmid">22786879</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Everts</surname><given-names>B.</given-names></name><name><surname>Amiel</surname><given-names>E.</given-names></name><name><surname>Huang</surname><given-names>S.C.</given-names></name><name><surname>Smith</surname><given-names>A.M.</given-names></name><name><surname>Chang</surname><given-names>C.H.</given-names></name><name><surname>Lam</surname><given-names>W.Y.</given-names></name><name><surname>Redmann</surname><given-names>V.</given-names></name><name><surname>Freitas</surname><given-names>T.C.</given-names></name><name><surname>Blagih</surname><given-names>J.</given-names></name><name><surname>van der Windt</surname><given-names>G.J.</given-names></name></person-group><article-title>TLR-driven early glycolytic reprogramming via the kinases TBK1-IKK&#x003b5; supports the anabolic demands of dendritic cell activation</article-title><source>Nat. Immunol.</source><volume>15</volume><year>2014</year><fpage>323</fpage><lpage>332</lpage><pub-id pub-id-type="pmid">24562310</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Gillen</surname><given-names>K.M.</given-names></name><name><surname>Mubarak</surname><given-names>M.</given-names></name><name><surname>Nguyen</surname><given-names>T.D.</given-names></name><name><surname>Pitt</surname><given-names>D.</given-names></name></person-group><article-title>Significance and <italic>In&#x000a0;Vivo</italic> Detection of Iron-Laden Microglia in White Matter Multiple Sclerosis Lesions</article-title><source>Front. Immunol.</source><volume>9</volume><year>2018</year><fpage>255</fpage><pub-id pub-id-type="pmid">29515576</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Grootveld</surname><given-names>M.</given-names></name><name><surname>Bell</surname><given-names>J.D.</given-names></name><name><surname>Halliwell</surname><given-names>B.</given-names></name><name><surname>Aruoma</surname><given-names>O.I.</given-names></name><name><surname>Bomford</surname><given-names>A.</given-names></name><name><surname>Sadler</surname><given-names>P.J.</given-names></name></person-group><article-title>Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy</article-title><source>J.&#x000a0;Biol. Chem.</source><volume>264</volume><year>1989</year><fpage>4417</fpage><lpage>4422</lpage><pub-id pub-id-type="pmid">2466835</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Tang</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Song</surname><given-names>H.</given-names></name><name><surname>Tuong</surname><given-names>Z.K.</given-names></name><name><surname>Fu</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>C.</given-names></name></person-group><article-title>Mechanism of Iron Oxide-Induced Macrophage Activation: The Impact of Composition and the Underlying Signaling Pathway</article-title><source>J.&#x000a0;Am. Chem. Soc.</source><volume>141</volume><year>2019</year><fpage>6122</fpage><lpage>6126</lpage><pub-id pub-id-type="pmid">30933483</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Haeggstr&#x000f6;m</surname><given-names>J.Z.</given-names></name><name><surname>Funk</surname><given-names>C.D.</given-names></name></person-group><article-title>Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease</article-title><source>Chem. Rev.</source><volume>111</volume><year>2011</year><fpage>5866</fpage><lpage>5898</lpage><pub-id pub-id-type="pmid">21936577</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>C.J.</given-names></name><name><surname>Boyle</surname><given-names>R.H.</given-names></name><name><surname>Astin</surname><given-names>J.W.</given-names></name><name><surname>Flores</surname><given-names>M.V.</given-names></name><name><surname>Oehlers</surname><given-names>S.H.</given-names></name><name><surname>Sanderson</surname><given-names>L.E.</given-names></name><name><surname>Ellett</surname><given-names>F.</given-names></name><name><surname>Lieschke</surname><given-names>G.J.</given-names></name><name><surname>Crosier</surname><given-names>K.E.</given-names></name><name><surname>Crosier</surname><given-names>P.S.</given-names></name></person-group><article-title>Immunoresponsive gene 1 augments bactericidal activity of macrophage-lineage cells by regulating &#x003b2;-oxidation-dependent mitochondrial ROS production</article-title><source>Cell Metab.</source><volume>18</volume><year>2013</year><fpage>265</fpage><lpage>278</lpage><pub-id pub-id-type="pmid">23931757</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>C.J.</given-names></name><name><surname>Sanderson</surname><given-names>L.E.</given-names></name><name><surname>Lawrence</surname><given-names>L.M.</given-names></name><name><surname>Pool</surname><given-names>B.</given-names></name><name><surname>van der Kroef</surname><given-names>M.</given-names></name><name><surname>Ashimbayeva</surname><given-names>E.</given-names></name><name><surname>Britto</surname><given-names>D.</given-names></name><name><surname>Harper</surname><given-names>J.L.</given-names></name><name><surname>Lieschke</surname><given-names>G.J.</given-names></name><name><surname>Astin</surname><given-names>J.W.</given-names></name></person-group><article-title>Blocking fatty acid-fueled mROS production within macrophages alleviates acute gouty inflammation</article-title><source>J.&#x000a0;Clin. Invest.</source><volume>128</volume><year>2018</year><fpage>1752</fpage><lpage>1771</lpage><pub-id pub-id-type="pmid">29584621</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Handa</surname><given-names>P.</given-names></name><name><surname>Thomas</surname><given-names>S.</given-names></name><name><surname>Morgan-Stevenson</surname><given-names>V.</given-names></name><name><surname>Maliken</surname><given-names>B.D.</given-names></name><name><surname>Gochanour</surname><given-names>E.</given-names></name><name><surname>Boukhar</surname><given-names>S.</given-names></name><name><surname>Yeh</surname><given-names>M.M.</given-names></name><name><surname>Kowdley</surname><given-names>K.V.</given-names></name></person-group><article-title>Iron alters macrophage polarization status and leads to steatohepatitis and fibrogenesis</article-title><source>J.&#x000a0;Leukoc. Biol.</source><volume>105</volume><year>2019</year><fpage>1015</fpage><lpage>1026</lpage><pub-id pub-id-type="pmid">30835899</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Hider</surname><given-names>R.C.</given-names></name><name><surname>Hoffbrand</surname><given-names>A.V.</given-names></name></person-group><article-title>The Role of Deferiprone in Iron Chelation</article-title><source>N.&#x000a0;Engl. J. Med.</source><volume>379</volume><year>2018</year><fpage>2140</fpage><lpage>2150</lpage><pub-id pub-id-type="pmid">30485781</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Hillar</surname><given-names>M.</given-names></name><name><surname>Lott</surname><given-names>V.</given-names></name><name><surname>Lennox</surname><given-names>B.</given-names></name></person-group><article-title>Correlation of the effects of citric acid cycle metabolites on succinate oxidation by rat liver mitochondria and submitochondrial particles</article-title><source>J.&#x000a0;Bioenerg.</source><volume>7</volume><year>1975</year><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">1176438</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Holmes-Hampton</surname><given-names>G.P.</given-names></name><name><surname>Ghosh</surname><given-names>M.C.</given-names></name><name><surname>Rouault</surname><given-names>T.A.</given-names></name></person-group><article-title>Methods for Studying Iron Regulatory Protein 1: An Important Protein in Human Iron Metabolism</article-title><source>Methods Enzymol.</source><volume>599</volume><year>2018</year><fpage>139</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">29746238</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Infantino</surname><given-names>V.</given-names></name><name><surname>Iacobazzi</surname><given-names>V.</given-names></name><name><surname>Menga</surname><given-names>A.</given-names></name><name><surname>Avantaggiati</surname><given-names>M.L.</given-names></name><name><surname>Palmieri</surname><given-names>F.</given-names></name></person-group><article-title>A key role of the mitochondrial citrate carrier (SLC25A1) in TNF&#x003b1;- and IFN&#x003b3;-triggered inflammation</article-title><source>Biochim. Biophys. Acta</source><volume>1839</volume><year>2014</year><fpage>1217</fpage><lpage>1225</lpage><pub-id pub-id-type="pmid">25072865</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Kakhlon</surname><given-names>O.</given-names></name><name><surname>Manning</surname><given-names>H.</given-names></name><name><surname>Breuer</surname><given-names>W.</given-names></name><name><surname>Melamed-Book</surname><given-names>N.</given-names></name><name><surname>Lu</surname><given-names>C.</given-names></name><name><surname>Cortopassi</surname><given-names>G.</given-names></name><name><surname>Munnich</surname><given-names>A.</given-names></name><name><surname>Cabantchik</surname><given-names>Z.I.</given-names></name></person-group><article-title>Cell functions impaired by frataxin deficiency are restored by drug-mediated iron relocation</article-title><source>Blood</source><volume>112</volume><year>2008</year><fpage>5219</fpage><lpage>5227</lpage><pub-id pub-id-type="pmid">18796625</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>H.M.</given-names></name><name><surname>Ahn</surname><given-names>S.H.</given-names></name><name><surname>Choi</surname><given-names>P.</given-names></name><name><surname>Ko</surname><given-names>Y.A.</given-names></name><name><surname>Han</surname><given-names>S.H.</given-names></name><name><surname>Chinga</surname><given-names>F.</given-names></name><name><surname>Park</surname><given-names>A.S.</given-names></name><name><surname>Tao</surname><given-names>J.</given-names></name><name><surname>Sharma</surname><given-names>K.</given-names></name><name><surname>Pullman</surname><given-names>J.</given-names></name></person-group><article-title>Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development</article-title><source>Nat. Med.</source><volume>21</volume><year>2015</year><fpage>37</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">25419705</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>B.</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>L.A.</given-names></name></person-group><article-title>Metabolic reprogramming in macrophages and dendritic cells in innate immunity</article-title><source>Cell Res.</source><volume>25</volume><year>2015</year><fpage>771</fpage><lpage>784</lpage><pub-id pub-id-type="pmid">26045163</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Kohler</surname><given-names>S.A.</given-names></name><name><surname>Henderson</surname><given-names>B.R.</given-names></name><name><surname>K&#x000fc;hn</surname><given-names>L.C.</given-names></name></person-group><article-title>Succinate dehydrogenase b mRNA of Drosophila melanogaster has a functional iron-responsive element in its 5&#x02032;-untranslated region</article-title><source>J.&#x000a0;Biol. Chem.</source><volume>270</volume><year>1995</year><fpage>30781</fpage><lpage>30786</lpage><pub-id pub-id-type="pmid">8530520</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Krawczyk</surname><given-names>C.M.</given-names></name><name><surname>Holowka</surname><given-names>T.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Blagih</surname><given-names>J.</given-names></name><name><surname>Amiel</surname><given-names>E.</given-names></name><name><surname>DeBerardinis</surname><given-names>R.J.</given-names></name><name><surname>Cross</surname><given-names>J.R.</given-names></name><name><surname>Jung</surname><given-names>E.</given-names></name><name><surname>Thompson</surname><given-names>C.B.</given-names></name><name><surname>Jones</surname><given-names>R.G.</given-names></name><name><surname>Pearce</surname><given-names>E.J.</given-names></name></person-group><article-title>Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation</article-title><source>Blood</source><volume>115</volume><year>2010</year><fpage>4742</fpage><lpage>4749</lpage><pub-id pub-id-type="pmid">20351312</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Kroner</surname><given-names>A.</given-names></name><name><surname>Greenhalgh</surname><given-names>A.D.</given-names></name><name><surname>Zarruk</surname><given-names>J.G.</given-names></name><name><surname>Passos Dos Santos</surname><given-names>R.</given-names></name><name><surname>Gaestel</surname><given-names>M.</given-names></name><name><surname>David</surname><given-names>S.</given-names></name></person-group><article-title>TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord</article-title><source>Neuron</source><volume>83</volume><year>2014</year><fpage>1098</fpage><lpage>1116</lpage><pub-id pub-id-type="pmid">25132469</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Lampropoulou</surname><given-names>V.</given-names></name><name><surname>Sergushichev</surname><given-names>A.</given-names></name><name><surname>Bambouskova</surname><given-names>M.</given-names></name><name><surname>Nair</surname><given-names>S.</given-names></name><name><surname>Vincent</surname><given-names>E.E.</given-names></name><name><surname>Loginicheva</surname><given-names>E.</given-names></name><name><surname>Cervantes-Barragan</surname><given-names>L.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>S.C.</given-names></name><name><surname>Griss</surname><given-names>T.</given-names></name></person-group><article-title>Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation</article-title><source>Cell Metab.</source><volume>24</volume><year>2016</year><fpage>158</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">27374498</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name><surname>Le</surname><given-names>N.T.</given-names></name><name><surname>Richardson</surname><given-names>D.R.</given-names></name></person-group><article-title>The role of iron in cell cycle progression&#x000a0;and the proliferation of neoplastic cells</article-title><source>Biochim. Biophys. Acta</source><volume>1603</volume><year>2002</year><fpage>31</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">12242109</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Cheng</surname><given-names>X.</given-names></name><name><surname>Yuan</surname><given-names>H.</given-names></name><name><surname>Zhu</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Wen</surname><given-names>Q.</given-names></name><name><surname>Xie</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Kroemer</surname><given-names>G.</given-names></name></person-group><article-title>PINK1 and PARK2 Suppress Pancreatic Tumorigenesis through Control of Mitochondrial Iron-Mediated Immunometabolism</article-title><source>Dev. Cell</source><volume>46</volume><year>2018</year><fpage>441</fpage><lpage>455.e8</lpage><pub-id pub-id-type="pmid">30100261</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name><surname>Loenarz</surname><given-names>C.</given-names></name><name><surname>Schofield</surname><given-names>C.J.</given-names></name></person-group><article-title>Expanding chemical biology of 2-oxoglutarate oxygenases</article-title><source>Nat. Chem. Biol.</source><volume>4</volume><year>2008</year><fpage>152</fpage><lpage>156</lpage><pub-id pub-id-type="pmid">18277970</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name><surname>Love</surname><given-names>M.I.</given-names></name><name><surname>Huber</surname><given-names>W.</given-names></name><name><surname>Anders</surname><given-names>S.</given-names></name></person-group><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biol.</source><volume>15</volume><year>2014</year><fpage>550</fpage><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name><surname>Mackay</surname><given-names>G.M.</given-names></name><name><surname>Zheng</surname><given-names>L.</given-names></name><name><surname>van den Broek</surname><given-names>N.J.</given-names></name><name><surname>Gottlieb</surname><given-names>E.</given-names></name></person-group><article-title>Analysis of Cell Metabolism Using LC-MS and Isotope Tracers</article-title><source>Methods Enzymol.</source><volume>561</volume><year>2015</year><fpage>171</fpage><lpage>196</lpage><pub-id pub-id-type="pmid">26358905</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>E.L.</given-names></name><name><surname>Kelly</surname><given-names>B.</given-names></name><name><surname>Logan</surname><given-names>A.</given-names></name><name><surname>Costa</surname><given-names>A.S.H.</given-names></name><name><surname>Varma</surname><given-names>M.</given-names></name><name><surname>Bryant</surname><given-names>C.E.</given-names></name><name><surname>Tourlomousis</surname><given-names>P.</given-names></name><name><surname>Dabritz</surname><given-names>J.H.M.</given-names></name><name><surname>Gottlieb</surname><given-names>E.</given-names></name><name><surname>Latorre</surname><given-names>I.</given-names></name></person-group><article-title>Succinate Dehydrogenase&#x000a0;Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory&#x000a0;Macrophages</article-title><source>Cell</source><volume>167</volume><year>2016</year><fpage>457</fpage><lpage>470.e13</lpage><pub-id pub-id-type="pmid">27667687</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>E.L.</given-names></name><name><surname>Ryan</surname><given-names>D.G.</given-names></name><name><surname>Prag</surname><given-names>H.A.</given-names></name><name><surname>Dikovskaya</surname><given-names>D.</given-names></name><name><surname>Menon</surname><given-names>D.</given-names></name><name><surname>Zaslona</surname><given-names>Z.</given-names></name><name><surname>Jedrychowski</surname><given-names>M.P.</given-names></name><name><surname>Costa</surname><given-names>A.S.H.</given-names></name><name><surname>Higgins</surname><given-names>M.</given-names></name><name><surname>Hams</surname><given-names>E.</given-names></name></person-group><article-title>Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1</article-title><source>Nature</source><volume>556</volume><year>2018</year><fpage>113</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">29590092</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal" id="sref45"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>M.P.</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>L.A.J.</given-names></name></person-group><article-title>Krebs Cycle Reimagined: The Emerging Roles of Succinate and Itaconate as Signal Transducers</article-title><source>Cell</source><volume>174</volume><year>2018</year><fpage>780</fpage><lpage>784</lpage><pub-id pub-id-type="pmid">30096309</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal" id="sref46"><person-group person-group-type="author"><name><surname>Nairz</surname><given-names>M.</given-names></name><name><surname>Schroll</surname><given-names>A.</given-names></name><name><surname>Sonnweber</surname><given-names>T.</given-names></name><name><surname>Weiss</surname><given-names>G.</given-names></name></person-group><article-title>The struggle for iron - a metal at the host-pathogen interface</article-title><source>Cell. Microbiol.</source><volume>12</volume><year>2010</year><fpage>1691</fpage><lpage>1702</lpage><pub-id pub-id-type="pmid">20964797</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal" id="sref47"><person-group person-group-type="author"><name><surname>Nakazawa</surname><given-names>M.S.</given-names></name><name><surname>Keith</surname><given-names>B.</given-names></name><name><surname>Simon</surname><given-names>M.C.</given-names></name></person-group><article-title>Oxygen availability and metabolic adaptations</article-title><source>Nat. Rev. Cancer</source><volume>16</volume><year>2016</year><fpage>663</fpage><lpage>673</lpage><pub-id pub-id-type="pmid">27658636</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal" id="sref48"><person-group person-group-type="author"><name><surname>Nathan</surname><given-names>C.</given-names></name><name><surname>Xie</surname><given-names>Q.W.</given-names></name></person-group><article-title>Nitric oxide synthases: roles, tolls, and controls</article-title><source>Cell</source><volume>78</volume><year>1994</year><fpage>915</fpage><lpage>918</lpage><pub-id pub-id-type="pmid">7522969</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal" id="sref49"><person-group person-group-type="author"><name><surname>Netz</surname><given-names>D.J.</given-names></name><name><surname>Stith</surname><given-names>C.M.</given-names></name><name><surname>St&#x000fc;mpfig</surname><given-names>M.</given-names></name><name><surname>K&#x000f6;pf</surname><given-names>G.</given-names></name><name><surname>Vogel</surname><given-names>D.</given-names></name><name><surname>Genau</surname><given-names>H.M.</given-names></name><name><surname>Stodola</surname><given-names>J.L.</given-names></name><name><surname>Lill</surname><given-names>R.</given-names></name><name><surname>Burgers</surname><given-names>P.M.</given-names></name><name><surname>Pierik</surname><given-names>A.J.</given-names></name></person-group><article-title>Eukaryotic DNA polymerases require an iron-sulfur cluster for the formation of active complexes</article-title><source>Nat. Chem. Biol.</source><volume>8</volume><year>2011</year><fpage>125</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">22119860</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal" id="sref50"><person-group person-group-type="author"><name><surname>N&#x000fa;&#x000f1;ez</surname><given-names>G.</given-names></name><name><surname>Sakamoto</surname><given-names>K.</given-names></name><name><surname>Soares</surname><given-names>M.P.</given-names></name></person-group><article-title>Innate Nutritional Immunity</article-title><source>J.&#x000a0;Immunol.</source><volume>201</volume><year>2018</year><fpage>11</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">29914937</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal" id="sref51"><person-group person-group-type="author"><name><surname>Pagani</surname><given-names>A.</given-names></name><name><surname>Nai</surname><given-names>A.</given-names></name><name><surname>Corna</surname><given-names>G.</given-names></name><name><surname>Bosurgi</surname><given-names>L.</given-names></name><name><surname>Rovere-Querini</surname><given-names>P.</given-names></name><name><surname>Camaschella</surname><given-names>C.</given-names></name><name><surname>Silvestri</surname><given-names>L.</given-names></name></person-group><article-title>Low hepcidin accounts for the proinflammatory status associated with iron deficiency</article-title><source>Blood</source><volume>118</volume><year>2011</year><fpage>736</fpage><lpage>746</lpage><pub-id pub-id-type="pmid">21628413</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal" id="sref52"><person-group person-group-type="author"><name><surname>Pandolfo</surname><given-names>M.</given-names></name><name><surname>Hausmann</surname><given-names>L.</given-names></name></person-group><article-title>Deferiprone for the treatment of Friedreich&#x02019;s ataxia</article-title><source>J.&#x000a0;Neurochem.</source><volume>126</volume><issue>Suppl 1</issue><year>2013</year><fpage>142</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">23859349</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal" id="sref53"><person-group person-group-type="author"><name><surname>Papathanassiu</surname><given-names>A.E.</given-names></name><name><surname>Ko</surname><given-names>J.H.</given-names></name><name><surname>Imprialou</surname><given-names>M.</given-names></name><name><surname>Bagnati</surname><given-names>M.</given-names></name><name><surname>Srivastava</surname><given-names>P.K.</given-names></name><name><surname>Vu</surname><given-names>H.A.</given-names></name><name><surname>Cucchi</surname><given-names>D.</given-names></name><name><surname>McAdoo</surname><given-names>S.P.</given-names></name><name><surname>Ananieva</surname><given-names>E.A.</given-names></name><name><surname>Mauro</surname><given-names>C.</given-names></name><name><surname>Behmoaras</surname><given-names>J.</given-names></name></person-group><article-title>BCAT1 controls metabolic reprogramming in activated human macrophages and is associated with inflammatory diseases</article-title><source>Nat. Commun.</source><volume>8</volume><year>2017</year><fpage>16040</fpage><pub-id pub-id-type="pmid">28699638</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal" id="sref54"><person-group person-group-type="author"><name><surname>Papazyan</surname><given-names>R.</given-names></name><name><surname>Sun</surname><given-names>Z.</given-names></name><name><surname>Kim</surname><given-names>Y.H.</given-names></name><name><surname>Titchenell</surname><given-names>P.M.</given-names></name><name><surname>Hill</surname><given-names>D.A.</given-names></name><name><surname>Lu</surname><given-names>W.</given-names></name><name><surname>Damle</surname><given-names>M.</given-names></name><name><surname>Wan</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Briggs</surname><given-names>E.R.</given-names></name></person-group><article-title>Physiological Suppression of Lipotoxic Liver Damage by Complementary Actions of HDAC3 and SCAP/SREBP</article-title><source>Cell Metab.</source><volume>24</volume><year>2016</year><fpage>863</fpage><lpage>874</lpage><pub-id pub-id-type="pmid">27866836</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal" id="sref55"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>B.T.</given-names></name><name><surname>Manz</surname><given-names>D.H.</given-names></name><name><surname>Torti</surname><given-names>F.M.</given-names></name><name><surname>Torti</surname><given-names>S.V.</given-names></name></person-group><article-title>Mitochondria and iron: current questions</article-title><source>Expert Rev. Hematol.</source><volume>10</volume><year>2017</year><fpage>65</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">27911100</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal" id="sref56"><person-group person-group-type="author"><name><surname>Peyssonnaux</surname><given-names>C.</given-names></name><name><surname>Cejudo-Martin</surname><given-names>P.</given-names></name><name><surname>Doedens</surname><given-names>A.</given-names></name><name><surname>Zinkernagel</surname><given-names>A.S.</given-names></name><name><surname>Johnson</surname><given-names>R.S.</given-names></name><name><surname>Nizet</surname><given-names>V.</given-names></name></person-group><article-title>Cutting edge: essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis</article-title><source>J.&#x000a0;Immunol.</source><volume>178</volume><year>2007</year><fpage>7516</fpage><lpage>7519</lpage><pub-id pub-id-type="pmid">17548584</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal" id="sref57"><person-group person-group-type="author"><name><surname>Recalcati</surname><given-names>S.</given-names></name><name><surname>Locati</surname><given-names>M.</given-names></name><name><surname>Marini</surname><given-names>A.</given-names></name><name><surname>Santambrogio</surname><given-names>P.</given-names></name><name><surname>Zaninotto</surname><given-names>F.</given-names></name><name><surname>De Pizzol</surname><given-names>M.</given-names></name><name><surname>Zammataro</surname><given-names>L.</given-names></name><name><surname>Girelli</surname><given-names>D.</given-names></name><name><surname>Cairo</surname><given-names>G.</given-names></name></person-group><article-title>Differential regulation of iron homeostasis during human macrophage polarized activation</article-title><source>Eur. J. Immunol.</source><volume>40</volume><year>2010</year><fpage>824</fpage><lpage>835</lpage><pub-id pub-id-type="pmid">20039303</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal" id="sref58"><person-group person-group-type="author"><name><surname>Recalcati</surname><given-names>S.</given-names></name><name><surname>Gammella</surname><given-names>E.</given-names></name><name><surname>Buratti</surname><given-names>P.</given-names></name><name><surname>Doni</surname><given-names>A.</given-names></name><name><surname>Anselmo</surname><given-names>A.</given-names></name><name><surname>Locati</surname><given-names>M.</given-names></name><name><surname>Cairo</surname><given-names>G.</given-names></name></person-group><article-title>Macrophage ferroportin is essential for stromal cell proliferation in wound healing</article-title><source>Haematologica</source><volume>104</volume><year>2019</year><fpage>47</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">30115660</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal" id="sref59"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>M.D.</given-names></name><name><surname>McCarthy</surname><given-names>D.J.</given-names></name><name><surname>Smyth</surname><given-names>G.K.</given-names></name></person-group><article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title><source>Bioinformatics</source><volume>26</volume><year>2010</year><fpage>139</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">19910308</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal" id="sref60"><person-group person-group-type="author"><name><surname>Rudolf</surname><given-names>J.</given-names></name><name><surname>Makrantoni</surname><given-names>V.</given-names></name><name><surname>Ingledew</surname><given-names>W.J.</given-names></name><name><surname>Stark</surname><given-names>M.J.</given-names></name><name><surname>White</surname><given-names>M.F.</given-names></name></person-group><article-title>The DNA repair helicases XPD and FancJ have essential iron-sulfur domains</article-title><source>Mol. Cell</source><volume>23</volume><year>2006</year><fpage>801</fpage><lpage>808</lpage><pub-id pub-id-type="pmid">16973432</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal" id="sref61"><person-group person-group-type="author"><name><surname>Selak</surname><given-names>M.A.</given-names></name><name><surname>Armour</surname><given-names>S.M.</given-names></name><name><surname>MacKenzie</surname><given-names>E.D.</given-names></name><name><surname>Boulahbel</surname><given-names>H.</given-names></name><name><surname>Watson</surname><given-names>D.G.</given-names></name><name><surname>Mansfield</surname><given-names>K.D.</given-names></name><name><surname>Pan</surname><given-names>Y.</given-names></name><name><surname>Simon</surname><given-names>M.C.</given-names></name><name><surname>Thompson</surname><given-names>C.B.</given-names></name><name><surname>Gottlieb</surname><given-names>E.</given-names></name></person-group><article-title>Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase</article-title><source>Cancer Cell</source><volume>7</volume><year>2005</year><fpage>77</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">15652751</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal" id="sref62"><person-group person-group-type="author"><name><surname>Sindrilaru</surname><given-names>A.</given-names></name><name><surname>Peters</surname><given-names>T.</given-names></name><name><surname>Wieschalka</surname><given-names>S.</given-names></name><name><surname>Baican</surname><given-names>C.</given-names></name><name><surname>Baican</surname><given-names>A.</given-names></name><name><surname>Peter</surname><given-names>H.</given-names></name><name><surname>Hainzl</surname><given-names>A.</given-names></name><name><surname>Schatz</surname><given-names>S.</given-names></name><name><surname>Qi</surname><given-names>Y.</given-names></name><name><surname>Schlecht</surname><given-names>A.</given-names></name></person-group><article-title>An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice</article-title><source>J.&#x000a0;Clin. Invest.</source><volume>121</volume><year>2011</year><fpage>985</fpage><lpage>997</lpage><pub-id pub-id-type="pmid">21317534</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal" id="sref63"><person-group person-group-type="author"><name><surname>Soares</surname><given-names>M.P.</given-names></name><name><surname>Hamza</surname><given-names>I.</given-names></name></person-group><article-title>Macrophages and Iron Metabolism</article-title><source>Immunity</source><volume>44</volume><year>2016</year><fpage>492</fpage><lpage>504</lpage><pub-id pub-id-type="pmid">26982356</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal" id="sref64"><person-group person-group-type="author"><name><surname>Sohn</surname><given-names>Y.S.</given-names></name><name><surname>Breuer</surname><given-names>W.</given-names></name><name><surname>Munnich</surname><given-names>A.</given-names></name><name><surname>Cabantchik</surname><given-names>Z.I.</given-names></name></person-group><article-title>Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications</article-title><source>Blood</source><volume>111</volume><year>2008</year><fpage>1690</fpage><lpage>1699</lpage><pub-id pub-id-type="pmid">17975016</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal" id="sref65"><person-group person-group-type="author"><name><surname>Solinas</surname><given-names>G.</given-names></name><name><surname>Bor&#x000e9;n</surname><given-names>J.</given-names></name><name><surname>Dulloo</surname><given-names>A.G.</given-names></name></person-group><article-title>De novo lipogenesis in metabolic homeostasis: more friend than foe?</article-title><source>Mol. Metab.</source><volume>4</volume><year>2015</year><fpage>367</fpage><lpage>377</lpage><pub-id pub-id-type="pmid">25973385</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal" id="sref66"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A.</given-names></name><name><surname>Tamayo</surname><given-names>P.</given-names></name><name><surname>Mootha</surname><given-names>V.K.</given-names></name><name><surname>Mukherjee</surname><given-names>S.</given-names></name><name><surname>Ebert</surname><given-names>B.L.</given-names></name><name><surname>Gillette</surname><given-names>M.A.</given-names></name><name><surname>Paulovich</surname><given-names>A.</given-names></name><name><surname>Pomeroy</surname><given-names>S.L.</given-names></name><name><surname>Golub</surname><given-names>T.R.</given-names></name><name><surname>Lander</surname><given-names>E.S.</given-names></name><name><surname>Mesirov</surname><given-names>J.P.</given-names></name></person-group><article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>Proc. Natl. Acad. Sci. USA</source><volume>102</volume><year>2005</year><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal" id="sref67"><person-group person-group-type="author"><name><surname>Sumimoto</surname><given-names>H.</given-names></name></person-group><article-title>Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species</article-title><source>FEBS J.</source><volume>275</volume><year>2008</year><fpage>3249</fpage><lpage>3277</lpage><pub-id pub-id-type="pmid">18513324</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal" id="sref68"><person-group person-group-type="author"><name><surname>Suragani</surname><given-names>R.N.</given-names></name><name><surname>Zachariah</surname><given-names>R.S.</given-names></name><name><surname>Velazquez</surname><given-names>J.G.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Sun</surname><given-names>C.W.</given-names></name><name><surname>Townes</surname><given-names>T.M.</given-names></name><name><surname>Chen</surname><given-names>J.J.</given-names></name></person-group><article-title>Heme-regulated eIF2&#x003b1; kinase activated Atf4 signaling pathway in oxidative stress and erythropoiesis</article-title><source>Blood</source><volume>119</volume><year>2012</year><fpage>5276</fpage><lpage>5284</lpage><pub-id pub-id-type="pmid">22498744</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal" id="sref69"><person-group person-group-type="author"><name><surname>Szklarczyk</surname><given-names>D.</given-names></name><name><surname>Franceschini</surname><given-names>A.</given-names></name><name><surname>Wyder</surname><given-names>S.</given-names></name><name><surname>Forslund</surname><given-names>K.</given-names></name><name><surname>Heller</surname><given-names>D.</given-names></name><name><surname>Huerta-Cepas</surname><given-names>J.</given-names></name><name><surname>Simonovic</surname><given-names>M.</given-names></name><name><surname>Roth</surname><given-names>A.</given-names></name><name><surname>Santos</surname><given-names>A.</given-names></name><name><surname>Tsafou</surname><given-names>K.P.</given-names></name></person-group><article-title>STRING v10: protein-protein interaction networks, integrated over the tree of life</article-title><source>Nucleic Acids Res.</source><volume>43</volume><year>2015</year><fpage>D447</fpage><lpage>D452</lpage><pub-id pub-id-type="pmid">25352553</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal" id="sref70"><person-group person-group-type="author"><name><surname>Tam</surname><given-names>F.W.</given-names></name><name><surname>Smith</surname><given-names>J.</given-names></name><name><surname>Morel</surname><given-names>D.</given-names></name><name><surname>Karkar</surname><given-names>A.M.</given-names></name><name><surname>Thompson</surname><given-names>E.M.</given-names></name><name><surname>Cook</surname><given-names>H.T.</given-names></name><name><surname>Pusey</surname><given-names>C.D.</given-names></name></person-group><article-title>Development of scarring and renal failure in a rat model of crescentic glomerulonephritis</article-title><source>Nephrol. Dial. Transplant.</source><volume>14</volume><year>1999</year><fpage>1658</fpage><lpage>1666</lpage><pub-id pub-id-type="pmid">10435873</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal" id="sref71"><person-group person-group-type="author"><name><surname>Tannahill</surname><given-names>G.M.</given-names></name><name><surname>Curtis</surname><given-names>A.M.</given-names></name><name><surname>Adamik</surname><given-names>J.</given-names></name><name><surname>Palsson-McDermott</surname><given-names>E.M.</given-names></name><name><surname>McGettrick</surname><given-names>A.F.</given-names></name><name><surname>Goel</surname><given-names>G.</given-names></name><name><surname>Frezza</surname><given-names>C.</given-names></name><name><surname>Bernard</surname><given-names>N.J.</given-names></name><name><surname>Kelly</surname><given-names>B.</given-names></name><name><surname>Foley</surname><given-names>N.H.</given-names></name></person-group><article-title>Succinate is an inflammatory signal that induces IL-1&#x003b2; through HIF-1&#x003b1;</article-title><source>Nature</source><volume>496</volume><year>2013</year><fpage>238</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">23535595</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal" id="sref72"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>M.G.</given-names></name><name><surname>Corey</surname><given-names>B.W.</given-names></name><name><surname>Si</surname><given-names>Y.</given-names></name><name><surname>Craft</surname><given-names>D.W.</given-names></name><name><surname>Zurawski</surname><given-names>D.V.</given-names></name></person-group><article-title>Antibacterial activities of iron chelators against common nosocomial pathogens</article-title><source>Antimicrob. Agents Chemother.</source><volume>56</volume><year>2012</year><fpage>5419</fpage><lpage>5421</lpage><pub-id pub-id-type="pmid">22850524</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal" id="sref73"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>W.H.</given-names></name><name><surname>Rouault</surname><given-names>T.A.</given-names></name></person-group><article-title>Functions of mitochondrial ISCU and cytosolic ISCU in mammalian iron-sulfur cluster biogenesis and iron homeostasis</article-title><source>Cell Metab.</source><volume>3</volume><year>2006</year><fpage>199</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">16517407</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal" id="sref74"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>W.H.</given-names></name><name><surname>Rouault</surname><given-names>T.A.</given-names></name></person-group><article-title>Metabolic regulation of citrate and iron by aconitases: role of iron-sulfur cluster biogenesis</article-title><source>Biometals</source><volume>20</volume><year>2007</year><fpage>549</fpage><lpage>564</lpage><pub-id pub-id-type="pmid">17205209</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal" id="sref75"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>W.H.</given-names></name><name><surname>Sourbier</surname><given-names>C.</given-names></name><name><surname>Kovtunovych</surname><given-names>G.</given-names></name><name><surname>Jeong</surname><given-names>S.Y.</given-names></name><name><surname>Vira</surname><given-names>M.</given-names></name><name><surname>Ghosh</surname><given-names>M.</given-names></name><name><surname>Romero</surname><given-names>V.V.</given-names></name><name><surname>Sougrat</surname><given-names>R.</given-names></name><name><surname>Vaulont</surname><given-names>S.</given-names></name><name><surname>Viollet</surname><given-names>B.</given-names></name></person-group><article-title>The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels</article-title><source>Cancer Cell</source><volume>20</volume><year>2011</year><fpage>315</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">21907923</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal" id="sref76"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>W.H.</given-names></name><name><surname>Maio</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>D.L.</given-names></name><name><surname>Palmieri</surname><given-names>E.M.</given-names></name><name><surname>Ollivierre</surname><given-names>H.</given-names></name><name><surname>Ghosh</surname><given-names>M.C.</given-names></name><name><surname>McVicar</surname><given-names>D.W.</given-names></name><name><surname>Rouault</surname><given-names>T.A.</given-names></name></person-group><article-title>TLR-activated repression of Fe-S cluster biogenesis drives a metabolic shift and alters histone and tubulin acetylation</article-title><source>Blood Adv.</source><volume>2</volume><year>2018</year><fpage>1146</fpage><lpage>1156</lpage><pub-id pub-id-type="pmid">29784770</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal" id="sref77"><person-group person-group-type="author"><name><surname>Tyrakis</surname><given-names>P.A.</given-names></name><name><surname>Yurkovich</surname><given-names>M.E.</given-names></name><name><surname>Sciacovelli</surname><given-names>M.</given-names></name><name><surname>Papachristou</surname><given-names>E.K.</given-names></name><name><surname>Bridges</surname><given-names>H.R.</given-names></name><name><surname>Gaude</surname><given-names>E.</given-names></name><name><surname>Schreiner</surname><given-names>A.</given-names></name><name><surname>D&#x02019;Santos</surname><given-names>C.</given-names></name><name><surname>Hirst</surname><given-names>J.</given-names></name><name><surname>Hernandez-Fernaud</surname><given-names>J.</given-names></name></person-group><article-title>Fumarate Hydratase Loss Causes Combined Respiratory Chain Defects</article-title><source>Cell Rep.</source><volume>21</volume><year>2017</year><fpage>1036</fpage><lpage>1047</lpage><pub-id pub-id-type="pmid">29069586</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal" id="sref78"><person-group person-group-type="author"><name><surname>Vinchi</surname><given-names>F.</given-names></name><name><surname>Costa da Silva</surname><given-names>M.</given-names></name><name><surname>Ingoglia</surname><given-names>G.</given-names></name><name><surname>Petrillo</surname><given-names>S.</given-names></name><name><surname>Brinkman</surname><given-names>N.</given-names></name><name><surname>Zuercher</surname><given-names>A.</given-names></name><name><surname>Cerwenka</surname><given-names>A.</given-names></name><name><surname>Tolosano</surname><given-names>E.</given-names></name><name><surname>Muckenthaler</surname><given-names>M.U.</given-names></name></person-group><article-title>Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease</article-title><source>Blood</source><volume>127</volume><year>2016</year><fpage>473</fpage><lpage>486</lpage><pub-id pub-id-type="pmid">26675351</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal" id="sref79"><person-group person-group-type="author"><name><surname>Vinothkumar</surname><given-names>K.R.</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Hirst</surname><given-names>J.</given-names></name></person-group><article-title>Architecture of mammalian respiratory complex I</article-title><source>Nature</source><volume>515</volume><year>2014</year><fpage>80</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">25209663</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal" id="sref80"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>J.M.</given-names></name><name><surname>Davies</surname><given-names>L.C.</given-names></name><name><surname>Karwan</surname><given-names>M.</given-names></name><name><surname>Ileva</surname><given-names>L.</given-names></name><name><surname>Ozaki</surname><given-names>M.K.</given-names></name><name><surname>Cheng</surname><given-names>R.Y.</given-names></name><name><surname>Ridnour</surname><given-names>L.A.</given-names></name><name><surname>Annunziata</surname><given-names>C.M.</given-names></name><name><surname>Wink</surname><given-names>D.A.</given-names></name><name><surname>McVicar</surname><given-names>D.W.</given-names></name></person-group><article-title>Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors</article-title><source>J.&#x000a0;Clin. Invest.</source><volume>128</volume><year>2018</year><fpage>3794</fpage><lpage>3805</lpage><pub-id pub-id-type="pmid">29920191</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="book" id="sref81"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>H.</given-names></name></person-group><chapter-title>ggplot2: Elegant Graphics for Data Analysis</chapter-title><year>2016</year><publisher-name>Springer-Verlag</publisher-name></element-citation></ref><ref id="bib82"><element-citation publication-type="journal" id="sref82"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>N.C.</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>L.A.J.</given-names></name></person-group><article-title>A Role for the Krebs Cycle Intermediate Citrate in Metabolic Reprogramming in Innate Immunity and Inflammation</article-title><source>Front. Immunol.</source><volume>9</volume><year>2018</year><fpage>141</fpage><pub-id pub-id-type="pmid">29459863</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal" id="sref83"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Xia</surname><given-names>R.</given-names></name><name><surname>Yue</surname><given-names>C.</given-names></name><name><surname>Zhai</surname><given-names>W.</given-names></name><name><surname>Du</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>Q.</given-names></name><name><surname>Cao</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Obando</surname><given-names>D.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name></person-group><article-title>ATF4 Regulates CD4<sup>+</sup> T Cell Immune Responses through Metabolic Reprogramming</article-title><source>Cell Rep.</source><volume>23</volume><year>2018</year><fpage>1754</fpage><lpage>1766</lpage><pub-id pub-id-type="pmid">29742431</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal" id="sref84"><person-group person-group-type="author"><name><surname>Zanganeh</surname><given-names>S.</given-names></name><name><surname>Hutter</surname><given-names>G.</given-names></name><name><surname>Spitler</surname><given-names>R.</given-names></name><name><surname>Lenkov</surname><given-names>O.</given-names></name><name><surname>Mahmoudi</surname><given-names>M.</given-names></name><name><surname>Shaw</surname><given-names>A.</given-names></name><name><surname>Pajarinen</surname><given-names>J.S.</given-names></name><name><surname>Nejadnik</surname><given-names>H.</given-names></name><name><surname>Goodman</surname><given-names>S.</given-names></name><name><surname>Moseley</surname><given-names>M.</given-names></name></person-group><article-title>Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues</article-title><source>Nat. Nanotechnol.</source><volume>11</volume><year>2016</year><fpage>986</fpage><lpage>994</lpage><pub-id pub-id-type="pmid">27668795</pub-id></element-citation></ref></ref-list><sec id="app2" sec-type="supplementary-material"><title>Supplemental Information</title><p id="p0250"><supplementary-material content-type="local-data" id="mmc1"><caption><title>Document S1. Figures S1&#x02013;S6 and Tables S1 and S2</title></caption><media xlink:href="mmc1.pdf"/></supplementary-material><supplementary-material content-type="local-data" id="mmc2"><caption><title>Document S2. Article plus Supplemental Information</title></caption><media xlink:href="mmc2.pdf"/></supplementary-material></p></sec><ack id="ack0010"><title>Acknowledgments</title><p>This work was supported by the <funding-source id="gs1">Medical Research Council</funding-source> (MR/M004716/1 and MR/N01121X/1, to J.B., and MRC_MC_UU_12022/6, to C.F.). We are grateful to Dr. Wing-Hang Tong (National Institute of Child Health and Human Development) for providing guidance on in-gel aconitase assays. We thank Hal Drakesmith for providing critical feedback on the manuscript.</p><sec id="sec5"><title>Author Contributions</title><p id="p0235">Conceptualization, J.B.; Methodology, J.B. and T.-D.C.; Investigation, M. Pereira, T.-D.C., N.B., A.O., M. Prendecki, J.-H.K., A.S.H.C., E.N., L.T., C.D.P., H.T.C., S.P.M., C.F., and J.B.; Writing &#x02013; Original Draft, J.B.; Writing &#x02013; Review &#x00026; Editing, J.B., T.-D.C., and C.F.; Visualization, J.B., T.-D.C., and C.F.; Supervision, J.B. and C.F.; Funding Acquisition, J.B. and C.F. All of the authors read and approved the final manuscript.</p></sec><sec sec-type="COI-statement" id="sec6"><title>Declaration of Interests</title><p id="p0240">The authors declare no competing interests.</p></sec></ack><fn-group><fn id="app1" fn-type="supplementary-material"><p id="p0245">Supplemental Information can be found online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.celrep.2019.06.039" id="intref0095">https://doi.org/10.1016/j.celrep.2019.06.039</ext-link>.</p></fn></fn-group></back></article>